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Abstract
Roles of cyclic nucleotides and cyclic nucleotide-dependent signaling molecules in regulating several
signaling pathways including cell migration have long been known. However, the new and revolutionary
concept is that it is not just the absence or presence of cyclic nucleotides, but a highly coordinated
balance between these molecules regulates cell migration. Multi-drug resistance protein 4 (MRP4), is a
member of the large family of ATP binding cassette (ABC) transporter proteins, that localizes to the
plasma membrane and functions as a nucleotide efflux transporter and thus plays a pivotal role in the
regulation of intracellular cyclic nucleotide dynamics. In our study we used MRP4-expressing fibroblast
cells and MRP4 knockout mice as model systems and wound healing assays as the experimental system
to explore this unique and emerging concept. Here we demonstrated for the first time that mouse
embryonic fibroblasts (MEFs) isolated from Mrp4-/- mice have higher intracellular cyclic nucleotide levels
and migrate faster compared to MEFs isolated from Mrp4+/+ mice. Using FRET based sensors specific
for cAMP and cGMP we showed that inhibition of MRP4 with MK571 moderately increases both cAMP
and cGMP levels and enhances the cell polarization leading to an increased cell migration. Whereas a
robust increase in cAMP levels was observed following treatment with forskolin and IBMX, which causes
decreased fibroblast migration. Cell migration appeared to be biphasic in response to externally added
cell-permeant cyclic nucleotides (cpt-cAMP and cptcGMP). Furthermore we identified actin as an integral
part of MRP4-interactome and these two proteins associate with each other predominantly at the plasma
membrane. We also observed that actin cytoskeleton restricts MRP4 to the specific micro-domains of
plasma membrane. Using FRET based sensor we showed that Mrp4-/- fibroblasts are more polarized
compared to the Mrp4+/+ cells with a higher compartmentalized cAMP levels and PKA activities near the
leading edge, which in turn lead to an enhanced cortical actin polymerization at the cell front. Taken
together our studies suggested a novel cAMP-dependent mechanism for MRP4-mediated regulation of
fibroblast migration where PKA and actin play critical roles as downstream targets.
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ABSTRACT
Roles of cyclic nucleotides and cyclic nucleotide-dependent signaling molecules
in regulating several signaling pathways including cell migration have long been known.
However, the new and revolutionary concept is that it is not just the absence or presence
of cyclic nucleotides, but a highly coordinated balance between these molecules regulates
cell migration. Multi-drug resistance protein 4 (MRP4), is a member of the large family
of ATP binding cassette (ABC) transporter proteins, that localizes to the plasma
membrane and functions as a nucleotide efflux transporter and thus plays a pivotal role in
the regulation of intracellular cyclic nucleotide dynamics. In our study we used MRP4expressing fibroblast cells and MRP4 knockout mice as model systems and wound
healing assays as the experimental system to explore this unique and emerging concept.
Here we demonstrated for the first time that mouse embryonic fibroblasts (MEFs)
isolated from Mrp4-/- mice have higher intracellular cyclic nucleotide levels and migrate
faster compared to MEFs isolated from Mrp4+/+ mice. Using FRET based sensors
specific for cAMP and cGMP we showed that inhibition of MRP4 with MK571
moderately increases both cAMP and cGMP levels and enhances the cell polarization
leading to an increased cell migration. Whereas a robust increase in cAMP levels was
observed following treatment with forskolin and IBMX, which causes decreased
fibroblast migration. Cell migration appeared to be biphasic in response to externally
added cell-permeant cyclic nucleotides (cpt-cAMP and cpt-cGMP). Furthermore we
identified actin as an integral part of MRP4-interactome and these two proteins associate
with each other predominantly at the plasma membrane. We also observed that actin
cytoskeleton restricts MRP4 to the specific micro-domains of plasma membrane. Using
FRET based sensor we showed that Mrp4-/- fibroblasts are more polarized compared to
the Mrp4+/+ cells with a higher compartmentalized cAMP levels and PKA activities near
the leading edge, which in turn lead to an enhanced cortical actin polymerization at the
cell front. Taken together our studies suggested a novel cAMP-dependent mechanism for
MRP4-mediated regulation of fibroblast migration where PKA and actin play critical
roles as downstream targets.
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CHAPTER 1.

MRP4 IN HEALTH AND DISEASE

An Overview of the Drug Transporter Family
The absorption, distribution and excretion of drugs largely depend on the uptake
and efflux drug transporters which control drug transport in and out of the cell
respectively (1,2). The virus-independent and alternative mechanism of drug resistance
relays on the expression and tissue-specific distribution of the efflux transporters.
ATP binding cassette transporters
The ATP binding cassette (ABC) transporters are predominantly located on the
plasma membrane and are involved in the extrusion of structurally diverse drugs and their
metabolites. Based on their two dimensional structure at the plasma membrane, they can
be classified into four distinct groups (i) P- glycol protein (P-gp), (ii) MRP1,2,3, (iii)
MRP4,5 and (iv) BCRP (1). These ABC transporters utilize the energy from ATP
hydrolysis to export their substrate against the concentration gradient. These active
transporters are thus capable of regulating the pharmacological behavior of drugs, drug
metabolites, drug conjugates, xenobiotics and the consequence of this altered drug
availability on the well-being of individual patients (3).
Multi-drug resistance protein
The multi-drug resistance protein (MRP) family currently has nine members
among which MRP1-8 are membrane localized. As organic anion transporters, MRPs
have diverse substrate populations among a wide range of anticancer and antiviral drugs
and thus are responsible for conferring most of the drug resistances during the period of
treatment (4). MRPs were first identified by Cole and group in 1992 as a second type of
drug pump beside the already studied P-gps (5). Unlike P-gps which only confer
resistance against neutral or slightly basic organic compounds, MRPs are more versatile
and can transport GSH, glucuronate or sulfate-conjugated drugs, organic anions like
methotrexate and several nucleoside analogues such as PMEA. The wide range of
substrate specificities including small molecules make MRPs prime targets to ameliorate
the unwanted effect of drug resistance (4).
Structure and Function of MRP4
Multi-drug resistance protein 4 (MRP4) is an ABC transporter that is localized
predominantly at the cell membrane (6). Together with cystic fibrosis transmembrane
conductance regulator (CFTR), it belongs to the ABCC subfamily. In 1999 it was first
identified as an efflux transporter of nucleoside-based antiviral drugs in T-lymphoid cell
lines (7).

1

MRP4/ABCC4 gene
MRP4 is the shortest member of the ABCC subfamily and contains only 1325
amino acids. It is encoded by the MRP4/ABCC4 gene that is located on chromosome
13q32.1. (3,8). The highly polymorphic MRP4 gene is comprised of 31 exons and 30
introns (9). Single nucleotide polymorphisms (SNPs) of the gene may lead to alterations
of expression, function and substrate specificity of MRP4. At least 25 non-synonymous
SNPs have been identified for MRP4 and those variants are clinically important for the
inter-patient variability of drug resistance. Exons 1a and 1b of the MRP4 gene can
undergo alternative splicing independently or in combination. Sometimes the alternative
splicing may lead to nonsense mutations due to premature termination codons (PTC) in
the mRNA transcripts (10). MRP4 expression can be regulated by these mechanisms
based on the specific cellular and molecular environments. Remarkably these PTC
producing exons are highly conserved in evolution for the truncated and non-functional
MRP4 encoding gene.
Structure of MRP4
1325 amino acids-long MRP4 consists of a conserved PDZ-binding motif at the
40 amino acid long C terminus. Structurally MRP4 has two membrane-spanning domains
(MSDs) and two cytosolic nucleotide-binding domains (NBDs) (11). Each membranespanning domain consists of six transmembrane helices (TMs). The NBDs bind and
hydrolyze ATP. The energy evolved by ATP hydrolysis, facilitates the substrate
transportation by MRP4 against the diffusion gradient. The phenylalanine residues at
positions 368 and 369 and glutamic acid residues at positions 374 and 387 in the highly
conserved TM6 are unique among MRP4s of different species but are not conserved for
other MRPs. The functionally important positively-charged arginine residues at position
375 and 782 are also absent in other MRPs. The homology model for MRP4 based on the
structure of other extensively-studied related MRPs indicated that these two arginine
molecules face into the pore at the membrane cytosol interface and probably play
important roles in substrate binding (1,3,8). Structure of MRP4 is shown in Figure 1-1.
Localization of MRP4
MRP4 is predominantly localized to the plasma membrane of multiple cell types.
It possesses differential tissue distributions with significant expressions in intestine,
blood capillaries, brain, liver, placenta and kidneys (3). As an efflux transporter MRP4
plays an important role in tissues with barrier functions like blood vessels. Expression of
MRP4 in lung microvessels is shown in Figure 1-2. An altered tissue distribution and
elevated expression of MRP4 were reported in several pathologic conditions including
prostate cancer (12-14). In contrast reduced mRNA level of MRP4 was reported for
malignant prostrate tumors. Susceptibility of MRP4 deficient mice for obstructive
cholestasis indicates the importance of the protein in regulating hepatic bile secretion
(15).
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Figure 1-1.

Structure of MRP4 protein

MRP4 protein topology showing several domains: two membrane spanning domains
(colored in pink) and two nucleotide binding domains (colored in yellow).
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Figure 1-2.

Expression of MRP4 in lung microvessels

Confocal images showed immunofluorescence of MRP4 (green) and nucleus (blue) in the
lung micro-vessels of mouse (left panel) and rat (right panel).
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Unlike other ABCC transporters, MRP4 exhibits dual membrane localization in
polarized cells. In contrast to renal proximal tubes where it is expressed at the apical
membrane, MRP4 was reported to be localized to the basolateral membrane of prostrate
tubuloacinar cells, hepatocytes and choroid plexus epithelial cells. In colonic epithelium
cells MRP4 was found to be present in both apical and basolateral plasma membranes (6)
whereas for brain capillaries the expression was reported to be in the luminal side of the
endothelium (16).
Substrates of MRP4
MRP4 is a member of ABC transporter family and it utilizes the energy of ATP
hydrolysis for the active efflux of its substrates (8,17). A diverse group of drugs and
endogenous compounds can be transported by MRP4 depending on the tissue distribution
and cellular environment in the vicinity of MRP4 molecules. In T lymphoid cell line, it
was first identified as an endogenous efflux transporter of nucleoside based antiviral
drugs like AZT, PMEA and Adefovir (7). Several anticancer drugs like MTX and
topothecan also showed MRP4-dependent transportation. The inhibitors of MRP4 (e.g.
MK571, sildenafil, probenecid) also act as substrates for MRP4 and competitively inhibit
the MRP4-mediated efflux of other substrates but they lack the specificity. MRP4 also
has a large number of endogenous substrates like cAMP, cGMP, bile acids,
prostaglandins, urate etc. Substrate binding sites allosterically regulate the transporter
activity of MRP4 presumably in a complex manner. For example previous reports
revealed that MRP4 binding of urate inhibits MTX efflux but stimulates cGMP transport
whereas cAMP transportation remains unaltered (18) indicating the presence of multiple
substrate binding sites in MRP4 structure (3).
MRP4-Dependent Cell Signaling
Several physiologically important molecules which are involved in diverse
intracellular and extracellular signaling pathways were found to be transported by MRP4.
By altering their cellular levels, MRP4 can regulate several signaling processes typically
in a compartmentalized fashion. This warrants the eligibility of MRP4 as a new
therapeutic target for several pathophysiological conditions.
Effect of MRP4 on cyclic nucleotide-mediated signaling
The small but elegant second messengers, cAMP and cGMP, are the first
identified endogenous substrate for MRP4 (19-21). MRP4 has very high affinities for
both cAMP and cGMP and the Km values obtained in vitro for cAMP and cGMP were
45µM (19) and 10/ 180 (18,19) respectively. However the affinities are highly variable
depending on the specie. Both cAMP and cGMP are important second messengers which
can regulate diverse cellular signaling processes via activation of their corresponding
protein kinases, PKA and PKG respectively. Though the existence of specific receptors
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for these cyclic nucleotides is still controversial, there are evidences indicating an active
transportation of cAMP and cGMP out of the cells. This probenecid sensitive efflux
mechanism is responsible for cyclic nucleotide or their active metabolite mediated intra
and extracellular signaling in a paracrine manner (22). As MRP4 is capable of
transporting cyclic nucleotides, it could regulate the intracellular and extracellular
concentrations of cyclic nucleotides along with different isoforms of phosphodiesterase
(PDEs). The whole cell concentrations of cyclic nucleotides are found to be slightly
altered in the absence of MRP4 in fibroblasts and pulmonary smooth muscle cells
(17,23).
In recent years increasing evidences are suggesting that the cyclic nucleotidedependent signalings are highly compartmentalized (24,25). Being a membrane protein,
MRP4 plays a critical role in regulating the compartmentalized cyclic nucleotides near or
at the plasma membrane. This fine-tuned localized modulation near the MRP4 molecules
directs the specific signaling flow rather than a global wave. For example, a
macromolecular complex between CFTR and MRP4 at the apical membrane regulates the
secretory properties of gut epithelia whereas in cardiac myocytes, this interaction plays
an important role for β-adrenergic-stimulated contraction. Both occur via the
compartmentalized alteration of cAMP dynamics (6,26). In the kidney MRP4 mediates
secretions of cAMP and cGMP into the primary urine and these secreted cyclic
nucleotides regulate the downstream signaling events either directly or via their
metabolites. This mechanism is important for maintaining water and salt homeostasis
(27). In addition, the absence of MRP4 altered the cAMP dynamics in leydig cells and
thus an attenuated luteinizing hormone-regulated testosterone production was observed in
Mrp4-/- mice (28). Since some of the PDE inhibitors like sildenafil and dipyrimadole are
also potent inhibitors of MRP4, some of those drugs’ effects can also be mediated
through MRP4 inhibition (29).
Effect of MRP4 on urate and eicosanoids-mediated signaling
Among the endogenous substrates urate and eicosanoids are also important
substrates for MRP4. In human body the end product of purine metabolism is urate which
regulates the free radical scavenging and immune response by conferring a danger signal.
In the kidney, together with the apical urate uptake transporter URAT1, MRP4 can
regulate the bidirectional renal handling of urate and hence can be a potential target for
the treatment of hyperuricaemia (30,31) . MRP4 can control the urate levels in blood
cells, liver, vascular smooth muscles and intestine as well by regulating the basolateral or
luminal efflux of urate.
Though eicosanoids like leukotrienes (LTB4 and LTC4) and prostanoids (PGE1,
PGE2 PGF2α and thromboxane B2) have very low affinity for MRP4, the eicosanoidsmediated important extracellular signaling process can be regulated by MRP4 in normal
physiological or pathological conditions (32,33). As some of the nonsteroidal antiinflammatory drugs can also inhibit MRP4, in addition to inhibit prostaglandin synthesis,
they can exert their effect by attenuating the prostaglandin secretion by MRP4. In
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addition, MRP4-deficient mice were found to exhibit a higher inflammatory pain
threshold and reduced prostanoids metabolites with altered cAMP dynamics (34).
Utilizing the energy of ATP hydrolysis, MRP4 is capable of transporting a wide
range of endogenous substrates like cyclic nucleotides and eicosanoids which play
important roles in the intra- and inter- cell signaling. A comprehensive exploration of
MRP4 mediated cellular signaling is important to understand the contribution of MRP4 in
health and disease.
Role of Cyclic Nucleotides in Cell Signaling
In the year of 1971, Dr. Eark W. Sutherland won the Noble prize for identifying
the first member of the family of secondary messengers- cyclic adenosine
monophosphate (cAMP) (35,36). Thereafter for more than 40 years cAMP and cGMP
have been recognized as important signaling molecules that regulate a myriad of
physiological processes like cell growth, migration, adhesions, fluid secretion,
metabolism, neuronal signaling and many more. An altered cyclic nucleotide signaling is
often associated with pathological conditions like cancer, fibrotic diseases, metabolic
diseases, neuronal disorders and defective immune response.(20,24,37,38). These simple
but elegant molecules carry the external signals inside the cell as secondary messengers.
Depending on the cell types, cell environment, localization and intensity of signal, they
can elicit different intracellular events in response to the same external cue (24).
Synthesis and regulation of cyclic nucleotides
Cyclic nucleotides, cAMP and cGMP, are synthesized from their nucleotide
triphosphate precursors (ATP and GTP) by the action of adenylyl cyclase (AC) and
guanylyl cyclase (GC) respectively. These cyclase catalysts are found in both cytosolic
soluble and particulate transmembrane forms (20,39,40) representing intracellular but
segregated populations of cyclic nucleotides. Nine membrane-bound and one cytosolic
AC isoforms have been identified. Similarly for GCs seven particulate and a single
soluble isoforms were found. The majority of the ACs get activated indirectly by ligands
like adrenergic agonists that bind to G protein couple receptors (GPCRs) and induce the
disassociation of Gαs subunit which in turn activates AC for cAMP synthesis. In contrast,
GCs get activated directly by their stimuli like natriuretic peptides, small paracrine
peptide hormones, cytokines (specific for particulate isoforms) and nitric oxide (specific
for the soluble isoform) (37,41,42).
After synthesis the cyclic nucleotides are degraded by the different isoforms of
phosphodiesterase (PDEs) to their corresponding mono phosphates (AMP and GMP).
Eleven different types of PDEs have been identified in mammalian cells. Among them
PDEs 4, 7 and 8 are specific for cAMP where as PDEs 5, 6 and 9 are specific for cGMP
and PDEs 1, 2, 3, 10 and 11 exhibit dual specificities for cAMP and cGMP. The diversity
of PDE isoforms ensure characteristic cyclic nucleotide dependent signaling in diverse
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cell or tissue types. Their subcellular localization and specific association with effector
and adaptor proteins also determine the compartmentalization of signaling events
involving cAMP and cGMP (24,38). Endogenous efflux transporters of cAMP and cGMP
(MRP4 and MRP5) play pivotal roles in this aspect. By regulating the active
transportation they can affect the global and subcellular concentration of cyclic
nucleotides and thus modulate various cyclic nucleotide-dependent biological processes
(17,20).
cAMP-dependent cell signaling
Depending on the cell type and subcellular localization, cAMP exerts its effect
primarily via activation of the cAMP-dependent kinase PKA and the exchange protein
activated by cAMP (EPAC). It can also directly activate the hyperpolarization-activated
cyclic nucleotide gated channels (HCN) and cyclic nucleotide gated channels (CNG) with
or without altering the membrane potentials. These channels play important roles in
cardiac rhythm, and olfaction (41). By activating EPAC which is a guanine nucleotide
exchange factor (GEF), cAMP can mediate several anti- and pro-apoptotic processes,
hormonal signaling, cardiac contraction and vascular permeability through PKA
independent mechanisms (43). EPAC can also activate the small G protein called RapI, to
mediate cell migration, adhesions, junction formation and secretions (41).
The holoenzyme PKA consists of two regulatory (R) and two catalytic subunits
(C). Upon cAMP binding PKA releases the active catalytic subunits which phosphorylate
their downstream target at serine/threonine residues. Four different R subunits (RIα, RIIα,
RIβ and RIIβ) and three catalytic subunits (Cα, Cβ and Cγ) can combine with each other
to form tetramers with two regulatory and two catalytic subunits and can exhibit
differential sensitivity, tissue distribution, subcellular localization and cellular response.
One key downstream effector of PKA is the basic/leucine zipper transcription factor
CREB which gets phosphorylated at serine 133 by PKA. The phosphorylation induces
the interaction between CREB and co-activator CBP and subsequent regulation of genes
involved in metabolism, signaling, proliferation, differentiation, oncogenesis and survival
(44).
cGMP-dependent cell signaling
The key mediator of cGMP-dependent signaling is cGMP dependent kinase PKG.
The specificity of the responses is largely determined by the subcellular localization of
cGMP and its effectors. In normal physiological conditions the concentration of cGMP is
ten-fold less than that of cAMP (45) and cGMP can activate a distinct population of
effectors for segregating its response from cAMP. The effects of cGMP on CNG are
important for regulation of photo transductions, natriuresis and water/electrolyte
homeostasis.
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PKG is a serine/threonine protein kinase which consists of homodimer of two
identical subunits. There are three PKG isoforms have been identified till date- PKGIα,
PKGIβ and PKGII. All the isoforms are widely distributed but exhibit specificity. PKGIα
is mainly located in lung, heart, cerebellum and platelets where in smooth muscles of
uterus, trachea and intestine both PKGIα and PKGIβ can be found and expression of
PKGII is restricted in brain, intestine and kidney. Different isoforms of PKG can regulate
diverse signaling processes involve in calcium activation, platelet aggregation, smooth
muscle contraction, cardiac regulation and gene expression. One of the critical
downstream effectors of PKG is β-catenin that regulates TCF/LEF mediated
transactivation and tumorigenesis (37,46).
Crosstalk between cAMP- and cGMP-dependent signaling processes
The complexity of cyclic nucleotides-dependent signaling pathways emerges from
the ability of cGMP to regulate the activity of PDE2 and PDE3 that can hydrolyze cAMP
with a higher affinity than cGMP. The aldosterone secretion by atrial natriuretic peptide
(ANP) is induced by a reduction in cAMP levels due to the cGMP mediated activation of
PDE2 (37,47).
An additional level of complexity arises by the crosstalk between PKA- and PKGmediated pathways. They share some common substrates that act as critical downstream
effectors in both cAMP- and cGMP-dependent signaling. Vasodilator-stimulated
phosphoprotein (VASP) can be phosphorylated by PKA at serine residue 157 and by
PKG at residue 239 and exerts differential effects on modulating focal adhesions, cell
migration, cell shape and platelet aggregation in response to external stimuli (48,49). In
addition, the activation of PKA and PKG by alternative cyclic nucleotides can also exert
dichotomous effect on complex signaling events.
The primary focus of this study is to monitor the flow of MRP4-dependent
biological processes like cell migration in real time and space. We wanted to understand
the role of MRP4 in regulating intracellular cyclic nucleotide dynamics in fibroblast cells
and how these altered cyclic nucleotide levels can critically influence the overall process
of cell migration.
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CHAPTER 2.

MECHANISM OF CELL MIGRATION

Cell migration is a byzantine process that required a concerted cross talk between
cell adhesion, cytoskeleton organization and membrane extensions. Traditionally the
process of cell migration consists of four distinct steps- 1) formation of leading edge
protrusions, 2) adhesion of the leading edge to the extracellular matrix (ECM), 3) forward
translocations of the cell body and 4) retraction of the trailing edge by releasing the
attachment at the cell rear (50,51).
The spatial regulation of the intracellular signaling can dynamically regulate the
segregation of the biochemical events that ensures an efficient cell migration.
Extracellular signals can be sensed and communicated inside the cell by specific
receptors which in turn direct the cell to extend membrane protrusions via actin
polymerization. Establishment of polarity is very important for directional cell migration
and the spatial distribution of signaling molecules and compartmentalized signaling play
critical roles in directing cell movement. The adhesive biomolecules aggregate at the cell
front to facilitate the tethering of the cell protrusions to the substrum whereas the removal
of those molecules from the cell rear helps in the detachment of the trailing edge. In
addition the preferential contraction of actomyosin at the cell front pulls the cell body in
forward direction. However several regulatory steps are involved in directional cell
migration and dysregulation of any of those steps leads to catastrophic consequences
(52). The two main theories for directional cell migration areCytoskeletal model- there are rapid actin polymerization at the cell front and
extensive interaction of cytoskeleton elements with the plasma membrane (53).
Membrane flow model- extension of the leading edge occurs primarily by
addition of new membrane at the front of the cell. Actin filaments stabilize the
added membrane so that a structured extension or lamella can be formed (54).
The migratory phenotypes are determined by interaction between cell and the
environment. The fast moving cells (maximum migration speed up to 10 µm/min) like
immune cells and tumor cells do not have highly organized cytoskeleton and possess
weak adhesion properties. Thus they can move in a fast amoeboid fashion. In contrast the
slow moving cells like fibroblast and epithelial precursors (maximum migration speed 1
µm/min) exhibit elaborate cytoskeleton structures and adhesions (51). However these two
cell types can switch between each other and can also move in groups depending on the
external cues.
Importance of Cell Migration
Directed cell migration accompanies us from birth to death. Not only implantation
but also morphogenesis throughout the embryonic development requires wellorchestrated migratory phenomena. In adults cell migration also regulates the immune-
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surveillance and the tissue repairing process. The importance of cell migration is not
limited to human but is extended to unicellular and multicellular organisms and even to
plants (50). Cell types and migration conditions are the key determinants of mode of cell
migration although some effectors unanimously regulate migration regardless of the cell
type and mode of migration.
Embryonic developments
Life begins with a single zygote after the union of a sperm and egg cell. After
conception the zygote transforms into the blastocyst that consists of a ball of rapidly
dividing cells. This blastocyst migrates to the uterus. Placenta is formed for providing
nutrition to the developing embryo. Regulated migration of a large group of cells into the
blastocyst leads to gastrulation. Cells from various layers of gastrula eventually go
through strategic migration for development of different organs. For example, during
brain development primitive neuronal cells migrate at different layers, extend projections
as axons and dendrites and form synapses to allow complex learning and memory process
(55). This migratory developmental process accompanies us throughout the life and even
contributes to our death (50).
Wound healing
Wound healing is an intricate homeostatic process that comprises of four
sequential steps (1) hemostasis (2) inflammation, (3) proliferation and (4) remodeling
(56,57). Lack of proper cell migration leads to a defective would repair. Tissue injury
initiates mechanical signal as well as the chemotactic molecule secretions that attract
cells into the injured area. It also triggers the blood factor induced cascade of
inflammatory signal. In response to injury induced inflammation, fibroblasts first migrate
into the wound site and produce new, provisional extracellular matrix for facilitating
epithelialization (58).
Angiogenesis, collagen deposition, epithelialization and wound contraction by
myofibroblasts are the hall mark steps in the proliferative stage whereas in remodeling
stage the collagen rearrangements and apoptotic removal of unwanted cells are taken
place. Wound healing requires complex collaborative efforts of many cell types for
proliferation, migration, matrix synthesis and contraction (59).
The process of wound repair. Depending on the depth of wound various cell
types like fibroblasts, blood vessels, connective tissue, bone and cartilages get exposed.
After initial sealing by fibrin blood clot, platelets are recruited to the injury site where
they release the platelet-derived-growth factor (PDGF). Chemotactic PDGF induce the
recruitment of other inflammatory cells and stimulate the migration of fibroblasts,
epithelial and endothelial cells into the wound area.
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The inflammatory cells like neutrophils and leukocytes rapidly destroy the
pathogens in the wound site and activate the local fibroblasts and keratinocytes by
secreting proinflammatory cytokines. The cytokines like interleukin I (IL-I), Tumor
necrosis factor-α (TNF-α) amplify the neutrophil- and platelet-derived proliferative
signal. Eventually those neutrophils are replaced by macrophages which produce the
growth factors and cytokines to facilitate the process of wound healing (56,60).
Numerous cell-signaling events are required for this efficient and highly controlled
repairing process.
Origin of fibroblasts. Migration and proliferation of fibroblasts dynamically
regulate the entire process of wound healing. Fibroblasts are derived from mesenchymal
origin and they are the major component of connective tissue in most vertebrates. In
contrast to myocytes that form collagen IV, fibroblasts are responsible for producing
interstitial collagen I, III, IV and IV (61) and can be classified based on their
morphological and proliferative characteristics. They lack basement membrane and have
multiple sheet-like processes and extensions. Their oval nucleus contain 1or 2 nucleoli.
Their cytoplasm consists of a lot of granular material, rough endoplasmic reticulum and
prominent Golgi apparatus. Fibroblasts are pleomorphic, highly motile cells that contain
actin and myosin. Their contractility largely depends on the mechanical parameters of
surrounding environments.
Role of fibroblasts in wound healing. Migration of fibroblasts into the wound
area to produce new interstitial collagen and extracellular matrix (ECM) is a very critical
step for the repair process. Fibroblasts, for wound repair, mainly come from the
proliferation of the nearby connective tissue rather than from the recruitment of
circulating vascular precursors (62). At the late healing phase, fibroblasts start
proliferating after activated by the chemotactic cytokines TGF-α and TGF-β. These
activated fibroblasts lead to an increased synthesis of single strand collagen that get
polymerized and cross-linked in the newly synthesized metalloprotein-rich EM (63). At
this stage a population of fibroblasts transform into myofibroblasts that resemble smooth
muscle cells for their high content of α-smooth muscle actin. Myofibroblasts are usually
formed under tensile condition and are capable of generating high contractile force to
augment the wound closure (60,64).
Role of fibroblast in fibrosis. Fibrosis can be defined as replacement of normal
tissue structure by excessive accumulation of nonfunctional scar tissue. Transformation
of fibroblasts- to- myofibroblasts is controlled by a variety of growth factors, cytokines
and mechanical stress. Recently cAMP has been reported to inhibit the fibroblasts- tomyofibroblasts transformation in cardiac fibroblasts (65,66). This process plays a key
role in wound healing and maintenance of tissue homeostasis. But an increased number
of myofibroblasts, that express higher level of α-smooth muscle actin, lead to
overproduction of collagen. Collagen is the most abundant protein that provides strength,
structure and integrity to the normal tissue. In injured tissue, collagen involves in
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repairing and restoration of the structure and function. But excess deposition of collagen
leads to tissue fibrosis. Strategies have been applied to attenuate collagen synthesis for
preventing the unwanted tissue fibrosis (66,67).
Immunity
Immunity is another homeostatic process that depends on cell migrations. Cells of
immune system (mainly leukocytes) are recruited to the injury site or to the invading
microorganisms from the circulation. They phagocytize these microbes and destroy them
by potent digestive enzymes. The constant surveillance by the circulating immune cells
protects our body from invading foreign substances. In the early stage of development,
they migrate through the lymphoid tissues and thymus, and acquire the self-recognition
property. Therefore they are capable of combating infections without destroying our own
body cells (68). Endothelial cells respond to the inflammatory signal by exposing new
receptors and by immobilizing the immune cells. Leukocytes translocate to the affected
tissue eventually and exert their immune function. Other antigen- presenting cells like
macrophages and dendritic cells carry the pathogens to lymph nodes and instruct the Bor T-lymphocytes to fight against the infection. However the efficient migration of
immune cells is very critical for providing immune protection to our body.
Pathophysiology
Cell migration is a crucial process in the development and maintenance of
multicellular organisms. Embryonic development, wound healing and immune responses,
all require the finely tuned cell migration. Erroneous cell migration leads to delayed
wound healing, vascular disease, tumor formation and metastasis. Induction of abnormal
migratory signal leads to catastrophic pathological conditions by migration of wrong cells
at the wrong place. Interestingly the major problem associated with cell-based therapy is
defective migration.
Defects in the regulation of several migration related proteins result in embryonic
lethality, malformed embryos or congenital abnormalities due to the disorganized and
inappropriate migration of the component cells. On the other hand up regulation of those
proteins are implicated in several chronic inflammations. For example in asthma, the
constant presence of leukocytes leads to chronic airway inflammation in response to
inhaled allergens which in turn causes hyper reactivity and severe tissue damage. In
autoimmune disorders like rheumatoid arthritis, the continuous migration of
inflammatory cells to the specific compartments and destruction of the tissues lead to
severe joint pain and impaired limb function.
During the process of metastasis cancer cells migrate from the initial site of tumor
to distal organs where they continue to proliferate and form secondary tumor mass. The
metastatic tumor cells exhibit an invasive phenotype with loss of cell- cell interaction and
increased cell motility. Several cytokine and growth factors are up regulated in those
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highly motile cancer cells. Finally the hyper proliferation and enhanced migration of
vascular smooth muscle cells leads to atherosclerosis by progressive thickening of blood
vessels. The vascular injury triggers inflammatory signal for leukocyte recruitment and
consequent fibrous plaque (69).
Taken together the regulation of cell migration is very important for the efficient
treatment of many pathological conditions like cancer, angiogenesis and autoimmune
disorders, multiple sclerosis, psoriasis and Crohn’s disease, all of which exhibit defective
migratory components (70). Pathological conditions like non-healing ulcers often
associate with abundant neutrophil infiltration, high concentration of reactive oxygen
species and destructive enzymes and therefore delayed healing. New strategies to treat all
those pathological conditions require a comprehensive understanding of all the complex
biological processes that dynamically regulate cell migration.
Regulation of Cell Migration
From simple unicellular organism to complex multi cellular mammals, all
requires cell migration as a fundamental process. In unicellular organisms the
requirement for cell migration is restricted to food searching and mating (71). The
specialization and complexity of multicellular organisms exploit the migration process
for tissue organization, organ-development and homeostasis (50,52).
Component process of cell migration
As a highly integrated molecular event, cell migration is actually conceptualized
as a cyclic process (72). The oscillatory cycles of membrane extension and retraction at
cell front regulate the velocity and direction of cell migration. Steps involved in cell
migration process are distinctly visible in slow moving cells like fibroblasts but are not as
obvious in fast moving cells like neutrophils (50). In addition, depending on the
migratory environment diverse molecular machineries can uniquely regulate the mode of
migration. However both fibroblastic and amoeboid motility share some common
features where they get polarize to extend the protrusion in the direction of migration.
Figure 2-1 is illustrating the polarization of a migrating fibroblast.
Protrusion formation. The de novo formation of membrane extension in the
direction of cell migration is called protrusions. Protrusions consist of three major
components-1) Formation of extension at the cell front by expansion of cell membrane,
2) Stabilization of the extension by cytoskeletons and 3) formation of new adhesions with
the substrum which provide the necessary traction force for the cell movement (51,52).
Actin polymerization is the driving force for protrusion formation. Depending on
the actin filaments organization; the protrusions can be classified into two groups-
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Figure 2-1.

Polarization of migrating fibroblast

The illustration showed organization of actin cytoskeleton and microtubules, the
protrusion and adhesion formation at cell front and rear, the reorientation of Golgi
apparatus and microtubules -organizing center (MTOC) towards the leading edge in a
migrating fibroblast.
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1) Lamellipodium- a flat protrusion formed by the branched dendritic network of
actin filaments (50).
2) Filopodium- a spike like protrusion formed by long, parallel bundles of actin
filaments (73).
The primary purpose of filopodia is to sense and explore the local environment
whereas with a broad and flat structure, lamellipodia are able to push a wide section of
plasma membrane in the direction of cell migration. Two major types of protein regulate
the actin nucleation in the protrusions- Apr 2/3 complex, and the formins mDia1 and 2
(49,73). Apr2/3 binds to the sides or tips of pre-existing actin filaments and induces the
formation of new actin filaments from the pointed end and at 70o angle (73).
During migration the WASP/WAVE family members get activated at the cell
membrane by Rac GTPase and induce the localized activation of Apr 2/3. Cdc42
phosphorylation can also regulate Apr 2/3 via WASP/WAVE. In contrast to Apr 2/3,
formins bind to the barbed end and induce the linear extension of the existing actin
filament for stabilizing the filopodia. By filament treadmilling mechanism actin filaments
elongate at their barbed ends while releasing actin monomer from their pointed ends. As
a result long and unbranched filaments bundles are formed rather that the branched
nucleation in the filopodia.
Ena/VASP proteins predominantly express at the tip of filopodia and antagonize
both capping and branching. Hence VASP promotes elongation of actin filaments. Small
GTPase including RhoA and Cdc42 can regulate formins and filopodia formations.
Profilin promotes the actin polymerization in G-actin bound state via interaction with
formins and regulates Ena/VASP mediated actin polymerization as an anti-capping agent
(49,74,75). Actin filament severing proteins like ADF/cofilin generate actin monomer by
disassembling the older filaments and by promoting dissociation from the pointed end to
facilitate the actin polymerization. In contrast the capping proteins like gelsolin restrict
the new filament growth near the plasma membrane (76-78). However the unbending of
the elongated actin filament against the leading edge, provides the driving force for the
extension of membrane protrusions (79).
Rho GTPases play pivotal roles in adhesion and protrusion formations (80,81).
They are active at GTP bound state and capable of interacting with downstream targets.
GEFs can activate them whereas GAPs cause their inactivation. Among the Rho
GTPases, Rac, Cdc42 and RhoA are required for lamellipodia, filopodia and stress fiber
formation respectively. They are also regulated by WASP/WAVE proteins and thus a
feedback loop controls the Rac/Cdc42 mediated actin polymerization (72). Apart from
the Rho GTPases, Src family kinases and phosphoinositides are also involved in
protrusion formation (77).
Adhesion dynamics. Cell makes adhesions with the substrum during gliding by
adhesive molecular interaction. The assembly and disassembly of the adhesions
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dynamically regulate cell migration in response to an external cue. New adhesions grow
in size and intensity in a temporal wave and persist until they reach the cell rear. Thus
they facilitate the cell migration over them (82,83). Though more than 150 protein
molecules are involved in adhesion formation, integrins are playing a major part is this
aspect. Integrins are heterodimeric receptors that consist of α and β chain with large
ligand binding and short cytoplasmic domains (84). They bind to several extracellular
matrix ligand and regulate cytoskeleton organization and therefore protrusion formation
by initiating intracellular signaling like tyrosine phosphorylation, activation of small
GTPases, synthesis of phospholipids and adhesion stabilization.
Integrins can be activated by proteins like talin, vinculin, α-actinin, small
GTPases and PKC. They are preferentially localized to the leading edge of a migrating
cell where new adhesions form. The phosphorylation of integrins disrupts the interaction
between integrin and adaptor protein paxillin resulting in release of paxillin for
stabilizing the lamellipodia (50,85,86). The large integrin mediated adhesion clusters are
found mostly in the focal adhesions of slow or non-migrating cells and involve in Rho
and myosin induced contractility. Rac and Cdc42 play important roles in formation of
focal complexes that mediate cells attachment to the ECM (50).
Cell polarization. This is the keystone for directional migration. A set of
interlinked feedback loops involving Rho family of GTPases, phosphoinositides 3kinases (PI3Ks), integrins, microtubules and vesicular transport help in establishing
differential molecular processes at the front and back of a migrating cell (80). Not only
the actin mediated protrusion formation or the trailing edge retraction, but also the
reorientation of Golgi apparatus and the microtubules -organizing center (MTOC) toward
the leading edge, define the cell polarity.
The master regulator of cell polarity, Cdc42, regulates the MTOC and Golgi
positioning through Par proteins and atypical PKC-dependent phosphorylation of dyneindynactin complex, and restricts the formation of lamellipodia at the cell front. It is also
involved in myosin dependent nuclear repositioning (80,87). Proper MOTC orientation is
essential for segregated microtubule growth in the lamella and restricted delivery of
Golgi derived vesicles to the leading edge to provide the membrane and necessary
proteins for forward protrusions (88,89).
In response to a shallow gradient of chemo-attractants, PIP3, PI(3,4)P2 get
polarized rapidly and the phosphatase PTEN remove them from cell sides and rear. These
processes are involved in localizing Cdc42 activation at cell front. Both inhibition and
global activation of Cdc42 lead to a disrupted directional migration (90).
On the other hand, Rac gets activated at the leading edge by PI3K mediated local
activation of Rac exchange factors. Rac can itself activate those PI3Ks and thus can form
a positive feedback loop at the leading edge. To induce directional migration Rac and
microtubules can activate each other. Integrin engagement plays role in activating and
membrane targeting Rac as well (88,91). The localized activations of PI3Ks, Cdc42 and
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Rac at the cell front are not enough for establishing cell polarity. The restricted activation
of Rho at the trailing edge is important for stabilizing microtubules and promoting the
adhesion turnover (88).
At the leading edge Rac activation suppresses Rho activation whereas at the sides
and rear of cells Rac activity gets suppressed by activation of Rho. This mutual
antagonistic activity is important for polarization of migrating cell (50).
Retraction of trailing edge. This is the final step of cell migration where cells
can actually move forward by detaching the adhesions at the rear. Tractional forces are
generated by integrin mediated interactions of intracellular cytoskeleton and ECM.
Migrating cells exert traction to the substrum during trailing edge retraction. The cell
attachments regulate the speed of migration in a biphasic manner and is determined by
the adhesive ligand on substrum, number of adhesion receptors on the cell surface and the
affinity of receptors for the ligands (51).
Interaction of Myosin II with actin cytoskeleton induces the tractional force at the
adhesions. Myosin II activity is dynamically regulated by myosin light chain (MLC)
phosphorylation by MLC kinases (MLCK), Rho kinases (ROCK) and MLC
phosphatases. In contrast to ROCK which is regulated by Rho GTP, MLCK is regulated
by intracellular calcium and phosphorylation (50,92).
Both at the front and the rear of a migrating cell, the disassembly of adhesion can
be observed for serving different purposes like protrusion formation and tail retraction
respectively. Tyrosine kinase like FAK and Src plays important roles in adhesion
turnover by regulating Rac specific GEFs and by activating mitogen activated protein
kinase MAPK/ERK at the leading edge (93,94).
New adhesion formation and turnover of old adhesion mediate the cell
translocation. The adhesions at the rear tether the cell strongly to the substrum and thus a
long tail of trailing edge is formed during migration of slow moving cells. This tension
can break the linkage between integrins and actin cytoskeleton and therefore integrin is
left behind on the substrum after the rest of the cell moves forward.
Myosin II and its activator PAK are important for this retraction event and the
deficiency of any of those proteins results in an impaired retraction and formation of
multiple pseudopods (50,51).
The tractional force induced stress elevates the intracellular calcium levels and
this calcium is implicated in adhesion disassembly by activating the focal adhesion
cleaving proteins like calcium regulated phosphatase calcineurin and calcium activated
protease calpain (95,96). However the release of adhesion at the cell rear is coupled to the
protrusion formation at the cell front and they dynamically regulate directional cell
migration.
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Cyclic nucleotide-dependent regulation of cell migration
Cyclic nucleotides play important roles in the signaling pathways at various
stages of the cell migration process, either directly or by activating their corresponding
kinases. It has long been known that cyclic nucleotides and their downstream signaling
molecules are involved in regulation of different types of cell migration (97,98). Earlier
some studies showed that cAMP and cGMP have opposing effect on cell migration; and,
according to the “Yin-Yang” hypothesis, cGMP stimulates whereas cAMP inhibits cell
migration (98). But the actual role of cAMP and cGMP in cell migration remains
controversial. The complex and equivocal effects of cAMP and cGMP on cell migration
ensure the importance of a tightly regulated and balanced intracellular cyclic nucleotide
levels for fine-tuned cell migration.
cAMP and cell migration. Studies in past few decades have revealed that cAMP
and cAMP-dependent protein kinase A (PKA) are important for localized cell protrusion
formation and efficient cell migration (99-101). PKA plays important role in F actin
arrangement by phosphorylating Hsp27 (102) The leading edge of a migrating cell
accumulates more PKA compared to the rest of the cell body, and this compartmentalized
activation of PKA is an important early step in directional cell migration.
In polarized cell, the gradient of PKA activity is maintained by a specific Akinase anchoring protein AKAP-Lbc (101). PKA has been found to both facilitate and
inhibit actin cytoskeleton rearrangements and cell migration because of the diversity of
the substrates for PKA.
But inhibition of PKA activity as well as interference with PKA anchoring causes
a defective pseudopod formation and an attenuated cell migration possibly in a Rac
GTPase-dependent fashion (103). In addition PKA can increase the epithelial cell
migration by reducing Rho activity and inducing focal adhesion turn over (104)
Paradoxically elevation of cAMP levels is reported to inhibit lamellipodia formation in
mouse embryonic fibroblast cells (MEFs) and mouse breast tumor cells by acting
downstream of small GTPase Rac (105). More over PKA activity establishes an
oscillatory cycles of membrane protrusion and retraction by phosphorylating RhoA and
increasing the interaction of RhoA with GDI (105).
cGMP and cell migration. The molecular mechanism of cGMP mediated
regulation of cell migration is still poorly understood. Recent studies showed that cGMPdependent protein kinase (PKG) activation attenuates phosphorylation of the actinsevering protein cofilin (Ser3) and therefore induces the formation of actin monomer for
polymerization of new filaments in the cell protrusions (39). Conversely adhesion and
migration of vascular smooth muscle cells (VSMC) increase in hypoxic conditions, due
to down regulation of PKG (106).
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Cells that overexpress VASP, a major substrate of PKG, have a higher protrusion
formation rate but a significantly slower cell migration rate (75). Phosphorylation of
VASP by PKG can relieve this overall negative effect on cell migration. The Rac GTPase
and PAK-dependent feedback mechanism plays pivotal role for maintaining the repetitive
behavior of cell migration. Additionally cGMP stimulates the activity of Rac and PAK
and thus facilitates the process of cell migration.
PKA and PKG both can exert differential effects on the contractility and tension
transmission in migrating cells by phosphorylation mediated activation of both myosin
light chain kinase and myosin phosphatase (39,49). Together cyclic nucleotides and
cyclic nucleotide-dependent kinases are involved in and regulate various signaling events
that compose cell migration.
Highly regulated PKA and PKG activities and therefore a tightly balanced
intracellular cyclic nucleotide levels are important for proper cell migration (17).
Hypothesis
Roles of cyclic nucleotides and cyclic nucleotide-dependent signaling molecules
in regulating several signaling events including cell migration have long been known.
However, the new and revolutionary concept is that it is not just the absence or presence
of cyclic nucleotides, but a highly coordinated balance between these molecules regulates
cell migration.
Multi-drug resistance protein 4 (MRP4) is a member of the large family of ATP
binding cassette (ABC) transporter proteins. It is localized to the plasma membrane and
functions as a nucleotide efflux transporter and thus plays a pivotal role in the regulation
of intracellular cyclic nucleotide dynamics.
In our study we used MRP4 expressing fibroblast cells and MRP4 knockout mice
as model systems and wound healing assays as the experimental system to explore this
unique and emerging concept. The unifying hypothesis of my study is thatInhibition of MRP4 increases the intracellular cyclic nucleotide (e.g. cAMP and
cGMP) levels in fibroblasts.
This altered cyclic nucleotide levels may have a role in regulating fibroblast
migration.
MRP4 interacting proteins may play some key roles in the regulation of fibroblast
migration.
Schematics of the hypothesis are shown in Figure 2-2.
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Figure 2-2.

Schematics of the hypothesis

The illustration showed the molecular mechanism of MRP4 dependent cell migration and
the role of cyclic nucleotides as effector molecules.
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Specific Aims
The specific aims of my study are the following –
Part 1: To determine the role of MRP4 in fibroblast migration


Subaim 1: To determine the expression and function of MRP4 in fibroblast cells.



Subaim 2: To study the role of MRP4 in regulating the intracellular cyclic
nucleotide dynamics in fibroblasts.



Subaim 3: To investigate the effect of cyclic nucleotides on cell migration.

Part 2: To investigate the importance of MRP4-interactome in fibroblast migration


Subaim 1: To identify the MRP4-interactome.



Subaim 2: To determine the effect of MRP4 containing macromolecular
complexes on cell migration.



Subaim 3: To identify the downstream targets of MRP4 that regulate cell
migration.
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CHAPTER 3.

MATERIAL AND METHODS*
Reagents

MRP4 inhibitor MK571 was obtained from Cayman Chemical (Ann Arbor, MI).
Forskolin was obtained from Tocris (Ellisville, MO). IBMX, Latrunculin B (Lat B), cptcAMP, and cpt-cGMP were purchased from Sigma-Aldrich (St. Louis, MO). Zaprinast
and PKA inhibitor H 89, 2HCl were purchased from Enzo Life Sciences (Farmingdale,
NY).
Cell Culture and Transfections
MEF cells and NIH 3T3 cells were cultured in DMEM media and MRP4
overexpressed and HEK 293 cells were grown in DMEM F-12 media (Invitrogen;
Carlsbad, CA) containing 10% FBS and 1% penicillin/streptomycin and maintained in
5% CO2 incubator at 37oC.
Mrp4+/+ and Mrp4-/- primary MEFs were transfected with 1 µg of total SV40
genomic DNA using Lipofectamine LTX (Invitrogen). Next day the transfected cells
were serially diluted (1000 to 10 cells per well) and plated in 96-well plates. SV40
immortalized clones were selected from the lower dilutions wells (17).
Lipofectamine 2000 (Invitrogen) was used for all transient transfections according
to the manufacturer’s instructions, and MRP4-overexpressing cell lines were generated
by using lentivirus vector and selected by puromycin (2 µg/ml).
Wound Healing Assay
According to the previously described method cell migration was measured using
in vitro wound healing assay. Wounds were made in the confluent monolayers of
fibroblast cells by scraping with a pipette tip across the monolayer. Cells were washed
thoroughly with PBS and incubated with warm media (107). Images of were taken with
100X magnification at the initial time of wounding and then at 6 h or 10 h postwounding. A cooled electron microscope (EM)-CCD camera (Hamamatsu; Bridgewater;
Denver, CO) was used for capturing the images. The cell migration was represented as a
percentage of initial wound length after analyzing by Image J software.

*

Adapted with permission. This research was originally published in The Journal of Biological Chemistry.
Sinha, C., Ren, A., Arora, K., Moon, C. S., Yarlagadda, S., Zhang, W., Cheepala, S. B., Schuetz, J. D., and
Naren, A. P. Multi-drug resistance protein 4 (MRP4)-mediated regulation of fibroblast cell migration
reflects a dichotomous role of intracellular cyclic nucleotides, (2013) J Biol Chem, 288, 3786-3794. © the
American Society for Biochemistry and Molecular Biology.

23

Animals
Mrp4-/- and Mrp4+/+ (C57BL/6) mice were provided by Dr. John Schuetz at St.
Jude Children's Research Hospital, Memphis, TN, USA (6,17).
Skin Explant Outgrowth Assay
Mice were euthanized by CO2 inhalation and cervical dislocation. Full thickness
dorsal skin biopsies (5 mm) were excised from 8 weeks old Mrp4-/- and Mrp4+/+ mice
after removing the hair. The skin patches were fixed in fibronectin-coated 6-well plates,
placing the dermal side down. The skin explants were cultured in DMEM media with
10% FBS and 1% penicillin/streptomycin and maintained in 5% CO2 incubator at 37oC
for 5 days (108,109). Representative images of the cellular outgrowth from each explant
were taken at 100X magnification. The proximal distance of cellular migration from the
edges of the skin patches was measured by Image J software.
High Content Microscopy
Fibroblast cells were grown in a fibronectin-coated 96-well Essen BioScience
Image-Lock microplate in a standard CO2 incubator for 24 hours. Precise wounds were
made by the 96-pin Wound-Maker provided with the IncuCyteTM. After that, cells were
washed thoroughly with PBS to remove the detached cells. Microplates were then placed
in the IncuCyteTM with appropriate media. At 1-h interval, the wound images were
automatically captured by IncuCyteTM (Essen Bioscience) from the incubator. The
relative wound density (RWD) kinetics were analyzed by IncuCyteTM software (110).
Crude-Membrane Isolation
Cells were washed with ice cold PBS for two times and then were harvested with
hypotonic buffer (10mM HEPES, 1mM EDTA, pH-7.2 and protease inhibitors: 1 mM
phenylmethylsulfonyl fluoride (PMSF), 1 μg/ml pepstatin A, 1 μg/ml leupeptin, and 1
μg/ml aprotinin). Then they were homogenized in hand held dounce (1ml) homogenizer
(20 strokes, three times with1 min interval) on the ice followed by centrifugation at 3000
rpm at 4oC for 10 min. The supernatant was collected as post nuclear supernatant (PNS).
Then the PNS was ultra-centrifuged at 35000 rpm for 1h at 4oC using Ti70.1 rotor
(Beckman Coulter, USA). After centrifugation the supernatant was collected as
cytoplasm and the crude membrane pellet was resuspended in hypotonic buffer. The
membrane suspension was sonicated in glass tube for 20sec for three times at 30 sec
interval to get a uniform suspension (111).Total protein concentrations were measured for
PNS, cytosol and membrane fraction using Bradford method and equal amounts of
proteins for each fraction were used for immunoblotting.
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Immunoblotting
For western blot, the cells were lysed in lysis buffer (1× PBS, containing 0.2%
Triton X-100 and protease inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF), 1
μg/ml pepstatin A, 1 μg/ml leupeptin, and 1 μg/ml aprotinin). Cell lysate was centrifuged
at 16,000 × g for 10 min at 4°C. The clear supernatant was collected and mixed with 5×
Laemmli sample buffer (containing 2.5% β-mercaptoethanol), denatured, subjected to
SDS-PAGE on 4–15% gel (Bio-Rad; Hercules, CA) and transferred to PVDF membrane.
The membrane was blocked with 5% non-fat milk and then was incubated with specific
primary antibodies.
We used anti-MRP4 antibody (rabbit polyclonal antibody) for MRP4 detection.
Anti-beta actin antibody (mouse) was purchased from Sigma-Aldrich Co. (St. Louis,
MO). VASP and phospho VASP (Ser157) antibodies were purchased from Cell Signaling
Technology (Danvers, MA) and PKA RIIα antibody was obtained from Transduction
Laboratories (Lexington, KY).
The chemiluminescence from the protein bands was detected using ECLTM
Western blotting detection reagents from GE Healthcare (Buckinghamshire, UK). 50µg
of total protein was loaded per lane (6,17).
Functional Assay for MRP4
Radioactive assay
Cells were plated at 500,000 cells/well in a 6 well plate with 2mls of DMEM
complete media. After two days the media were removed and cells were washed one time
with warm HBSS. Then10 µM of [3H] Bis (pom) PMEA or [3H] PMEA was added to
cells in DMEM media without any FBS. Cells were incubated for 24 hours and then the
media were aspirated.
For determining the whole cell uptake, cells were washed two times with ice cold
PBS to terminate the cellular uptake and lysed in 1 ml of 0.5N NaOH with continuous
agitation for 10 minutes. 500µl of lysate were neutralized with 300 ml of 0.1 M HCl. For
measuring the efflux rate, media was collected at 30 min interval for 1 hour. Then 4.5 ml
of scintillation fluid and 500µl of neutralized lysate or media were added to the
scintillation vials. The radioactivities of the samples were measured by Tri-Carb Liquid
Scintillation Counter (Perkin Elmer, Waltham, MA) (112-114).
Fluorescent assay
Approximately 24 hours after seeding, media were removed and cells were
washed twice with HBSS. The cells were then incubated with HBSS for equilibration.
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After 15 minute of equilibration period, HBSS was aspirated from the dish and the
experiment was initiated by the administration of solutions of 1.25 μM 8-FcA in presence
or absence of MRP4 inhibitor MK571.
Cellular uptake of 8-FcA was terminated by aspirating the substrate solution after
two hours of incubation and cells were washed three times with ice cold PBS. The cells
were extracted then using 200µl of a 50:50 solution of Methanol: Tris-EDTA (10 mM, 1
mM), pH 8.0 for approximately 10 minutes. The buffered extraction solution helps in
minimizing effect of pH on 8-FcA fluorescence. 50µl of the extract was transferred to a
black OptiPlate-96 for the fluorescence measurements (λex = 485 nm/λem = 535 nm)
using Fluostar Omega (BMG Labtech) microplate reader (115,116).
Fluorescence Resonance Energy Transfer Microscopy
CFP-EPAC-YFP was a generous gift from Dr. Kees Jalink (Division of Cell
Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The
Netherlands), Cygnet 2.1 was a generous gift from Dr. Wolfgang R Dostmann
(Department of Pharmacology, University of Vermont, Burlington, VT 05405, USA), and
the CFP tagged regulatory and YFP tagged catalytic subunit of PKA were a generous gift
from Dr. Manuela Zaccolo (Department Of Physiology, Anatomy & Genetics, University
of Oxford, UK) (117). Transfected cells were grown in 35-mm glass-bottomed dishes
(MatTek) for 24–48 h (117,118).
After washing with HBSS, cells were mounted on an Olympus microscopy
system for FRET imaging. Using the cooled CCD camera Hamamatsu ORCA285
(Hamamatsu, Japan) mounted on the Olympus microscope IX51 (U-Plan Fluorite 60 ×
1.25 NA oil-immersion objective) images were recorded. The system was controlled by
SlideBook 4.1 software (Intelligent Imaging Innovations; Denver, CO) and ratio modules
were used to obtain and analyze the images. A 300W Xenon lamp attenuated with a ND
filter with 50% light transmission provided the excitation light. Images were taken by a
JP4 CFP/YFP filter set (Chroma; Brattleboro, VT), including a 430/25-nm excitation
filter, a double dichroic beam splitter, and two emission filters (470/30-nm for CFP and
535/30-nm for FRET) alternated with a filter-changer Lambda 10–3 (Sutter Instruments;
Novato, CA).
With 100 ms exposure time, time-lapse images were taken at 1-min intervals.
Multiple regions of interest (ROIs) were selected on the cell after background subtraction
for quantitative data analysis (4–6 cells per condition). At different time points the
emission ratio images (CFP/FRET) were obtained as described previously. The
representative pseudo color images at 60X magnification were shown to indicate the
changes in the ratio of CFP to FRET intensity (118,119).
Membrane targeted pmAKAR3 and pmAKAR3-TA sensors were generous gifts
from Dr. Jin Zhang, (Department of Pharmacology and Molecular Sciences, The Johns
Hopkins University School of Medicine, Baltimore, MD 21205, USA). These sensors
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were used for monitoring PKA activity. PKA mediated phosphorylation increases the
FRET between the CFP and YFP tag. Cells transfected with pm AKAR3 sensor were
subjected to FRET measurement after background subtraction. FRET was normalized
with donor CFP intensity (FRET/CFP) to obtain the normalized corrected FRET (NFRET) which was represented as an index of PKA activity (120,121).
To confirm the specificity of this PKA sensor, we used the mutant PKA sensor
pmAKAR3-TA. This point mutant cannot be phosphorylated by PKA as it contains a
threonine-to-alanine mutation in the PKA substrate region. In basal condition it gives a
lower FRET value compare to pmAKAR3 and is not responsive to PKA activation.
Cyclic AMP and cGMP Measurement
Quantification of cAMP and cGMP were performed by specific competitive
immunoassay according to the manufacturer's instructions (Enzo Life Sciences, complete
ELISA kit for cAMP and cGMP). In brief cells were lysed in 0.1M HCl, and neutralized
with neutralizing agent. Those lysate were used for subsequent measurement of cyclic
nucleotides using the cAMP or cGMP specific rabbit polyclonal antibody and Goat anti‐
Rabbit IgG coated microtiter plates. As the concentration of cAMP is at least 10 fold
higher than that of cGMP inside the cells, the acetylation reagent (acetic anhydride to
triethylamine 1:2) was used during intracellular cGMP measurement for increasing the
assay sensitivity by 10 fold (17).
The Fluostar Omega (BMG Labtech) microplate reader was used to measure the
optical density at 405 nm. Standards, supplied with the kit, were run in parallel for the
quantitation of intracellular cyclic nucleotides.
Purification of HA-MRP4
HEK-293 cells, stably overexpressing hemagglutinin (HA)-MRP4 were seeded on
ten 100 mm dishes, and grown until completely confluent. The cells were then washed
twice with PBS and lysed with PBS containing 0.2% Triton-X-100 and
phenylmethylsulfonyl fluoride 1 mM, pepstatin-A 1 μg/ml, leupeptin 1 μg/ml, aprotinin 1
μg/ml. After lysis, the cell lysate was mixed for 15 min at 4°C and centrifuged at 13,000
rpm for 10 min.
HA-MRP4 were immunoprecipitated from the supernatant using α-HA beads for
overnight at 4°C. The beads were washed several times by centrifugation at 3,000 rpm for
1 min. The bead bound MRP4 was eluted with 100 mM glycine (pH 2.2) and neutralized
with 150 mM tris (pH 8.8). The eluted MRP4 containing macromolecular complexes
were run by SDS-PAGE on 4-15% gel (Bio-Rad, Hercules, CA) and then were visualized
with Gel Code Blue or immunoblotted with rabbit polyclonal MRP4 antibody.
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The MRP4 containing macromolecular complexes were subjected to mass
spectrum analysis for identifying the MRP4 interacting partners.
Cross Linking of IgG for Endogenous Immunoprecipitation
50µl of protein A/G (Santa Cruz SC2003) were taken into spin cup (Pierce 69700)
and washed twice with 200 ul PBS by centrifugation at 3,300 rpm/1,000 for 1 min). 510µg of IgG was added to the protein A/G in 100µl of PBS and mixed for 60 min at room
temperature. The protein A/G beads were washed two times with 400µl of PBS and 4.5µl
of freshly made 10 mM DSS stock with 94.5µl PBS were added to beads. The beads were
cross-linked with the antibody for 60 min at room temperature. After crosslinking the
beads were washed with 50µl of glycine elution buffer (Pierce 21004) for one time
followed by with 100µl of glycine elution buffer for two times.
The beads were resuspended and stored in PBS-0.2% TX100 at 4°C. These beads
were used for immunoprecipitations of endogenous MRP4 from MEFs.
Co-Immunoprecipitation
Mrp4-/- and Mrp4+/+ MEFs were lysed using lysis buffer-1X PBS, containing
0.2% Triton-X-100 and protease inhibitors. The supernatant was subjected to
immunoprecipitation using MRP4 rabbit polyclonal antibody conjugated protein A/G for
overnight at 4°C. The beads were washed several times by centrifugation at 3,000 rpm for
1 min and the MRP4 containing macromolecular complexes were eluted with 100 mM
glycine (pH 2.2) and neutralized with 150 mM Tris (pH 8.8). The eluted proteins were
mixed with the sample buffer (5X; containing 1% β-mercaptoethanol), denatured,
subjected to SDS-PAGE, transferred to PVDF membrane, and immunoblotted using goat
polyclonal anti-MRP4 antibody and anti-beta actin antibody (mouse).
Immunofluorescence
Cells were washed three times with PBS and fixed with 4% formaldehyde. After
washing three times with PBS, cells were permeabilized with 0.2% Triton X-100. After
washing three times with PBS, cells were blocked with 2.5% normal horse serum for
overnight at 4oC. Next day, cells were washed three times with PBST (PBS: Tween 80,
1:2000) for 5 minutes each. For immunostaining, the samples were incubated overnight
with respective primary antibodies and then washed three times with PBST for 5 minutes
each. Cells were then incubated with secondary Phalloidin Alexa Fluor 488 or anti Rabbit
Alexa Fluor 568 (Molecular Probes, Invitrogen) for 1 hour and mounted in DAPI
containing Vectashield, obtained from Vector (Burlingame, CA). Fluorescent images
were taken using a NikonA1R-A1 confocal microscope system (121,122).
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Protein Kinase A Activity Assay
Cells were lysed in Tris-based lysis buffer with PMSF 1 mM, pepstatin-A, 1
μg/ml leupeptin 1 μg/ml, aprotinin 1 μg/ml and 10 mM activated orthovanadate
(phosphatase inhibitor) and used for PKA activity assay using DetectX, PKA activity kit,
obtained from Arbor Assays (Ann Arbor, MI).
In brief, the lysate containing PKA phosphorylated the immobilized PKA
substrate on the microtiter plate in presence of ATP. Antibody specific for phospho-PKA
substrate recognized the immobilized phosphorylated substrate and got detected by
peroxidase conjugated anti rabbit IgG. The Fluostar Omega (BMG Labtech) microplate
reader was used to measure the optical density at 450 nm. Standards, supplied with the kit
were run in parallel for the quantitation of total PKA activity.
Single Particle Tracking
NIH3T3 cells stably expressing HA-MRP4 were grown on 35-mm glass-bottom
dishes (MatTek). Cells were washed with PBS containing 6 mM glucose and 1 mM
sodium pyruvate (PBS/Glu/NaPyr) for two times. PBS/Glu/NaPyr containing 4% BSA
was used for blocking the washed cells for 10 min. After blocking cells were incubated
with biotin conjugated α-HA antibody (1 μg/ml, Sigma) for 15 min, washed five times
with the HBSS followed by an incubation with streptavidin-conjugated Qdot-655 (0.1
nM, Invitrogen) for 2 min in absence of light.
After that cells were washed extensively for eight times, and mounted
immediately on the Olympus inverted microscope (IX51). The images were captured
using Hamamatsu EM-CCD camera at 1–3 frames per second for 1–3 min with 50-ms
exposure time, 100× oil-immersion objective (NA 1.40), xenon (300-W lamp) light
source, and SlideBook 4.2 software. Qdot 655-A Bright-Line high brightness and contrast
single band filter set (Semrock, Rochester, NY) was used for collecting data. Singleparticle tracking (SPT) was monitored by the particle-tracking module of SlideBook 4.2
software. The software generated trajectories for single Qdot and calculated the mean
square displacement (MSD) and diffusion coefficient (D). Data obtained from five to ten
cells were used for plotting histograms of the diffusion coefficient (121).
To monitor changes in lateral diffusion of MRP4 in fibroblasts with cytoskeletal
disruption, cells were pretreated with Lat B (1 μM, 30 min) or DMSO (as control), and
they were also added to the buffer during the course of the experiment.
Measurement of Protein Concentration
Protein concentrations were measured by Bradford Assays using Bio-Rad protein
assay dye. BSA was used as standard. Samples or standards were dissolved in 800µl of
distilled water and then 200µl of dye was added. The absorbance was measured at 595nm
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using spectrophotometer. Protein concentrations for each sample were calculated using
BSA based standard curve.
Ingenuity Pathway Analysis
With the help of Ingenuity Pathway Analysis we assigned MRP4 as seed and the
MRP4 interacting proteins as high confidence (HC) interactome (123,124). Then we
checked the interconnectivity between those proteins in the context of cell migration,
using the “shortest path” explorer which also includes the intermediate proteins involved
in the pathway based on literature and experimental evidences. Subsequently we
identified specific migration related signaling events that are regulated by certain nodes
in the interactome network.
Statistical Analysis
The mean values of different groups were compared by two tailed student’s t-test
and P values less than 0.05 were considered as significant. All the data were presented as
mean ± SEM where n indicated the number of experiments.
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CHAPTER 4.

RESULTS*

Expression of MRP4 in Fibroblasts
Multi-drug resistance protein 4 (MRP4/ABCC4) is a membrane protein that
belongs to the C subfamily of ATP-binding cassette (ABC) transporters family. MRP4
utilizes the energy of ATP hydrolysis to translocate the substrates across the membrane
(3,7). MRP4 is found to be expressed predominantly on plasma membrane of various cell
types in tissues with barrier functions like intestine, blood capillaries, brain, liver,
placenta and kidney. We wanted to see the expression of MRP4 in MEF cells isolated
from Mrp4-/- and Mrp4+/+ mice. To show the membrane specific expression of MRP4, we
isolated the post nuclear supernatant (PNS), cytoplasm and crude membrane fraction
from the Mrp4-/- and Mrp4+/+ MEFs. We loaded equal amount of protein (50 µg) for all
different fractions and immune-probed for MRP4 using anti-MRP4 antibody (rabbit
polyclonal antibody). As expected, we found that in Mrp4+/+ MEFs, MRP4 is present
predominantly at the membrane fraction. Though the total PNS fraction also showed
MRP4 expressions, the cytoplasm fraction did not exhibit any significant MRP4
expression. However we did not find any MRP4 expression in the post nuclear
supernatant (PNS), cytoplasm and membrane fractions of Mrp4-/- MEFs (Figure 4-1).
These data indicated that MRP4 is expressed in plasma membrane of the fibroblast cells.
Function of MRP4 in Fibroblasts
After confirming the membrane specific expression of MRP4, we tried to measure
the function of MRP4 in fibroblasts cells using whole cell PMEA uptake and PMEA
efflux assays. MRP4 was first identified as an efflux transporter of nucleoside based
antiviral drugs in human T-lymphoid cell lines (7) and it has a very high affinity for
PMEA (Km> 1000) (125). Therefore we used radiolabeled [3H] PMEA as MRP4
substrate to monitor MRP4 activity. When we measured the whole cell [3H] PMEA
uptake, we found that due to the absence of MRP4 mediated efflux process, Mrp4-/MEFs accumulate significantly higher amount of PMEA inside the cell compare to
Mrp4+/+ MEFs (Figure 4-2A).Similarly when we measured the PMEA efflux at different
time points after incubating the cells with [3H] PMEA, we found that the absence of
MRP4 significantly reduces the PMEA efflux rate in Mrp4-/- MEFs compare to the
Mrp4+/+ MEFs (Figure 4-2B). From these observations we confirmed that in fibroblast
cells, MRP4 is predominantly expressed at the plasma membrane and functions as an
endogenous efflux transporter.

*

Adapted with permission. This research was originally published in The Journal of Biological Chemistry.
Sinha, C., Ren, A., Arora, K., Moon, C. S., Yarlagadda, S., Zhang, W., Cheepala, S. B., Schuetz, J. D., and
Naren, A. P. Multi-drug resistance protein 4 (MRP4)-mediated regulation of fibroblast cell migration
reflects a dichotomous role of intracellular cyclic nucleotides, (2013) J Biol Chem, 288, 3786-3794. © the
American Society for Biochemistry and Molecular Biology.
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Figure 4-1.

Expression of MRP4 in MEF cells

The immunoblot data using anti-MRP4 antibody (rabbit polyclonal antibody) showed the
expressions of MRP4 in post nuclear supernatant (PNS), cytosol (Cyto) and membrane
(Mem) fractions of Mrp4-/- and Mrp4+/+ MEFs.
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Figure 4-2.

Functional assay for MRP4

MRP4 function was measured using [3H] PMEA as MRP4 substrate. (A) Bar graphs
represented the whole cell PMEA uptakes for Mrp4-/- and Mrp4+/+ MEFs. (B) Line
graphs represented the PMEA efflux rates in Mrp4-/- and Mrp4+/+ MEFs. All data
represented at least three independent experiments (n=3). * indicated P <0.05.
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MRP4 Deficient Mice Fibroblasts Migrate Rapidly and Heal Wounds Faster
Cyclic nucleotides and cyclic nucleotide dependent kinases play important roles
in different hallmark steps of cell migration (39,99). Among various endogenous
substrates, MRP4 has higher affinity for cAMP and cGMP (3,21). Therefore MRP4 can
regulate the intracellular cyclic nucleotide level and MRP4 deficient cells have altered
cyclic nucleotides dynamics. These altered levels of cyclic nucleotide can lead to a
modified cAMP/cGMP dependent signaling pathways including cell migration (23,126).
Therefore we hypothesized that in absence of MRP4, fibroblast cells will exhibit an
altered cyclic nucleotide dynamic and therefore a change in migration kinetics. To test
the effect of MRP4 on cell migration we first performed the conventional in-vitro scratch
wound assay. For our study we used two most commonly used fibroblasts, 1) mouse
embryonic fibroblast cells (MEFs) and 2) NIH 3T3 cell line. We generated MEFs from
wild type and Mrp4-/- mice to confirm the specific effect of MRP4 on cell migration
(127).
Uniform wounds were made on the confluent monolayers of Mrp4-/- and Mrp4+/+
MEFs treated with DMSO or MRP4 inhibitor MK571 using pipet tip. Then cell
migrations were monitored only for 6 hours to minimize the effect of cell proliferation.
When we measured the total cell migration for 6 hours as a percentage of initial wound
length using this conventional in-vitro wound healing assays, we found that Mrp4-/- MEF
cells migrate significantly faster compare to the wild type cells (Figure 4-3A). Similarly
when we treated wild type MEFs with MRP4 inhibitor MK571, the cell migration rate
significantly increased and they started migrating in a similar rate with Mrp4-/- MEF cells
(Figure 4-3A). These data indicated that inhibition of MRP4 can augment the fibroblast
cell migration. When we checked the MRP4 expressions in those cells by immunoblot,
we found that Mrp4-/- MEFs have no MRP4 expression but both MK571 treated and
untreated Mrp4+/+ MEFs have similar MRP4 expressions (Figure 4-3B). These data
indicated that MK571 antagonize MRP4 functions without affecting the expression and
therefore the rate of fibroblasts migration is inversely related to MRP4 function. Notably
all the cells had similar actin expressions.
To further support the data obtained by the conventional in-vitro wound healing
assays, we used high content microscopic technique to investigate the regulation of
fibroblast migration by MRP4 in-vitro. The precise wounds were made in the confluent
monolayer of MEFs isolated either from Mrp4-/- or Mrp4+/+ mice by the wound maker
and images were taken at 1hour interval for 18 hours using the IncuCyteTM live cell
imaging system. The Relative Wound Density (RDW) i.e. the spatial cell density inside
the wound area relative to the spatial cell density outside the wound area, at every time
point was measured. The RWD parameter is advantageous for being self-normalized to
the changes in cell density due to cell proliferation. The kinetics of RDW for Mrp4-/- and
Mrp4+/+ MEFs were depicted in Figure 4-4.
In agreement with our previous experiment the MRP4 deficient MEFs were found
to have faster RDW kinetics than wild type MEFs. All these data indicated that MRP4
has an inhibitory effect on MEFs migration.
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Figure 4-3.

MRP4 deficient fibroblasts migrate faster

(A)The conventional wound healing assay was performed on the confluent monolayers of
Mrp4-/- or Mrp4+/+or MK571 treated Mrp4+/+ MEFs and images were taken at 0th and
6th hour. The initial and final wound lengths were calculated and cell migrations were
represented as a percentage of initial wound length in the bar graph. (B) The immuneblots data showed the expression of MRP4 in Mrp4-/-, Mrp4+/+ and MK571 treated
Mrp4+/+ MEFs. All data represented at least three independent experiments (n=3).
* indicated P <0.05.
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Figure 4-4.
fibroblasts

High content microscopy shows higher RWD kinetics for Mrp4 -/-

Mrp4-/- or Mrp4+/+ MEFs were grown on fibronectin-coated 96-well Essen BioScience
ImageLock dishes and the wounds were made precisely using 96-pin Wound-Maker
provided with the IncuCyteTM. The kinetic of the Relative Wound Density (RWD) was
analyzed using IncuCyteTM software. All data represented at least three independent
experiments (n=3).
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MRP4 Overexpression Inhibits Fibroblast Migration
To further investigate the inhibitory effect of MRP4 on fibroblast cell migration
we used the conventional in-vitro wound healing assay with parental and MRP4
overexpressing NIH3T3 cell lines. HA-MRP4 (HA-tag was incorporated in between 751
and 752 glycine residues at the outer loop of MRP4) was introduced in NIH 3T3 cell
lines using lentivirus vector and HA-MRP4 overexpressing NIH3T3 cells were selected
by puromycin (2µg/ml). Those selected cells exhibited higher level of MRP4 expression
(Figure 4-5A) and significantly higher whole cell PMEA accumulation (Figure 4-5B)
compare to the control cell. These data indicated that the MRP4 overexpressing stable
cells have higher level of functionally active MRP4 compare to the control NIH3T3 cells.
To perform the conventional in-vitro scratch wound assay, uniform wound were
made using pipet tip on the confluent monolayers of control and HA-MRP4
overexpressing NIH3T3 cells and cell migrations were monitored for 10 hours due to
slow migration rate of the transfected cells. When we measured the total cell migration
for 10 hours as a percentage of initial wound length we found that MRP4 overexpressing
stable cells migrate significantly slower compare to the control NIH3T3 (Figure 4-6)
indicating a negative effect of MRP4 on fibroblast migration.
These data were further confirmed by high content microscopy. The precise
wounds were made in the confluent monolayer of control and HA-MRP4 overexpressing
NIH3T3 cells and images were taken at 1hour interval for 24 hours using the IncuCyteTM
live cell imaging system. The Relative Wound Density (RDW) at every time point was
measured. Data revealed slower RWD kinetics for NIH3T3 cells overexpressing MRP4
compare to the control cells (Figure 4-7). Together these in-vitro data suggested an
inhibitory effect of MRP4 on the fibroblast migration.
Mrp4-/- Fibroblasts Migrate Faster in Ex-vivo Skin Explant Assay
In addition the above mentioned in-vitro studies, we performed ex-vivo skin
explant outgrowth assay for investigating the role of MRP4 on skin fibroblasts. After
removing the hair, full thickness dorsal skin biopsies (5 mm) were excised from Mrp4-/and Mrp4+/+ mice. In fibronectin coated wells they were grown for 4 days. The fibroblast
cells started migrating out from the skin patches after 2days. Coating with fibronectin
(10µg/ml) helped the fibroblasts to migrate efficiently. Images of the cellular outgrowths
from each explant were taken by phase contrast microscope and the proximal distance of
cellular migration was measured by Image J software at day 4 post culture. The
representative 10X images of cellular outgrowth from skin explants at day 4 post culture
are shown in Figure 4-8A. An extensive halo of fibroblasts appeared around Mrp4-/- and
wild type mice skin explants but Mrp4-/- cells migrated 40% more rapidly than the wild
type fibroblasts (Figure 4-8B).These data suggested that MRP4 plays a key role in
regulating fibroblasts migration.

37

Figure 4-5. Expression and function of MRP4 in control and HA-MRP4
overexpressed NIH3T3 cells
(A) The immunoblot images are showing the expressions of MRP4 in control and HAMRP4 overexpressed NIH3T3 cells. MRP4 function was measured using [3H] PMEA as
MRP4 substrate. (B) Bar graphs represent the whole cell PMEA uptake of control and
HA-MRP4 overexpressed NIH3T3 cells. All data represented at least three independent
experiments (n=3). * indicated P <0.05.
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Figure 4-6.

Overexpression of MRP4 inhibits NIH3T3 fibroblasts migration

(A)The conventional wound healing assay was performed on the confluent monolayers of
control and HA-MRP4 overexpressed NIH3T3 cells and images were taken at 0th and
10th hour. The initial and final wound lengths were calculated and cell migrations were
represented as a percentage of initial wound length in the bar graph. All data represented
at least three independent experiments (n=3). * indicated P <0.05.
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Figure 4-7. High content microscopy shows slower RWD kinetics for MRP4
overexpressing NIH3T3 fibroblasts
Control and HA-MRP4 overexpressed NIH3T3 cells were grown on fibronectin-coated
96-well Essen BioScience ImageLock dishes and the wounds were made precisely using
96-pin Wound-Maker provided with the IncuCyteTM. The kinetic of the Relative Wound
Density (RWD) was analyzed using IncuCyteTM software. All data represented at least
three independent experiments (n=3).
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Figure 4-8.

Mrp4-/- fibroblasts show more outgrowths from the skin explants

5mm biopsy patches, isolated from skin of Mrp4-/- mice or wild type mice, were cultured
with appropriate media in fibronectin-coated (10µg/ml PBS) 6-well dishes. (A) The halo
of fibroblast cells came out from the skin explant and the images represent the 4th day
post seeding. (B) The proximal distance of the cellular out growth from the explant was
represented in bar graph. All data represented at least three independent experiments
(n=3). * indicated P <0.05.
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Inhibition of MRP4 Augments the Intracellular Cyclic Nucleotide Levels in
Fibroblasts
MRP4 is an endogenous efflux transporter of cyclic nucleotides and thereby
regulates the intracellular cAMP and cGMP dynamics. Among various endogenous
substrates, MRP4 has been reported to have the high affinity for cAMP (Km = 45µM)
and cGMP (Km=10/180µM) and these two cyclic nucleotides are very important
signaling molecules involved in multiple physiological and pathological events (3,19).
To investigate the effect of MRP4 inhibition on intracellular cyclic nucleotide
dynamics in live fibroblast cells we used the FRET Microscopy. We transiently
transfected the HA-MRP4 overexpressing NIH3T3 cells either with cAMP sensor CFPEPAC-YFP or with cGMP sensor, Cygnet 2.1. The cAMP-dependent conformational
change in Exchange protein directly activated by cAMP (EPAC) makes it a readily
targetable FRET-based sensor for measuring intracellular cAMP dynamics by fusing the
N terminus of EPAC with CFP and C terminus with the YFP analogue (118). Upon
cAMP binding, EPAC undergoes a conformational change and liberates the catalytic
domain, which moves CFP and YFP apart from each other to cause a reduced FRET
signal.
In cGMP-dependent protein kinase (PKG), a relatively larger conformational
change is induced by cGMP binding and almost a 100-fold higher selectivity was
observed for cGMP compared to cAMP. Hence PKG has been modified and flanked by
CFP and an improved pH-insensitive YFP variant to provide an efficient genetically
encoded FRET-based sensor for cGMP. Cygnet 2.1 has been developed to visualize
cGMP regulation in real time and space (119). Upon saturation, Cygnet 2.1 undergoes a
1.4 to 1.5-fold increase in cyan-to-yellow emission, and this dynamic range is
comparable to the cAMP sensor (128). The mechanism of FRET based sensors specific
for cAMP and cGMP is illustrated in Figure 4-9.
We were able to monitor the intracellular cAMP and cGMP dynamics with a very
high temporal and spatial resolution using these two unimolecular FRET based sensors.
Addition of 20µM of MRP4 inhibitor MK571 (6) induced an increase in the intracellular
cAMP level in fibroblast cells, which is represented by CFP/FRET emission ratio
(Figure 4-10). Similarly cGMP level also got increased by the addition of 20 µM MK571
(Figure 4-11). In both cases the effect was very rapid (within 30 sec). Together these
data confirmed that inhibition of MRP4 is responsible for increasing both intracellular
cAMP and cGMP levels. But the effect was more profound on cAMP compared to cGMP
possibly indicating a higher affinity of MRP4 for cAMP compare to cGMP in fibroblast
cells.
These FRET based fluorescent sensors not only resolved precise increase in
intracellular cAMP and cGMP levels, but also provide useful tools to determine the
functional efficacy of MRP4 inhibitors by monitoring of the inhibition of MRP4mediated cyclic nucleotides efflux in real-time.
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Figure 4-9.

Mechanism of FRET based sensors specific for cyclic nucleotides

The illustration showed the conformation changes in Epac and Cygnet 2.1 sensors upon
cAMP and cGMP binding respectively. The change in conformation takes the donor and
acceptor fluorophores apart from each other, which results in a reduced FRET signal.
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Figure 4-10. Inhibition of MRP4 augments intracellular cAMP levels
The pseudocolor images of CFP/FRET, before and 5 minute after addition of MK571
(20µM) for cells expressing cAMP sensor, were shown and the line graph indicated the
intracellular cAMP dynamics before and after addition of MK571 as a change in
CFP/FRET ratio. Images in each panel were captured from the same field of view. Color
bar showed the magnitude of the emission ratio. All data represented at least three
independent experiments (n=3).
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Figure 4-11. Inhibition of MRP4 augments intracellular cGMP levels
The pseudocolor images of CFP/FRET, before and 5 minute after addition MK571
(20µM) for cells expressing cGMP sensor, were shown and the line graph indicated
intracellular cGMP dynamics before and after addition of MK571 as a change in
CFP/FRET ratio. Images in each panel were captured from the same field of view. Color
bar showed the magnitude of the emission ratio. All data represented at least three
independent experiments (n=3).
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Increased Accumulation of Intracellular Cyclic Nucleotides in Mrp4-/- MEFs
As an efflux transporter of cyclic nucleotides, MRP4 can regulate the intracellular
cAMP and cGMP levels. Therefor in the absence of MRP4 there should be a diminished
cyclic nucleotides efflux rate and augmented intracellular cAMP/cGMP levels. Using the
highly sensitive FRET based cAMP sensor (CFP-EPAC-YFP) and cGMP sensor (Cygnet
2.1) we monitored the intracellular cyclic nucleotide levels in Mrp4-/- and Mrp4+/+ MEFs.
When we transfected Mrp4-/- and Mrp4+/+ MEFs with cAMP sensor we found that in the
absence of MRP4 the Mrp4-/-, MEFs show a higher basal level of intracellular cAMP
(Figure 4-12) compare to the MEFs which endogenously express MRP4. When we
treated the cAMP sensor transfected cells with 10µM forskolin, a global elevator of
cAMP, and 100µM IBMX, a nonspecific phosphodiesterase (PDE) inhibitor, the increase
in cAMP level was higher in Mrp4-/- MEFs compare to the Mrp4+/+ MEFs. We also
observed that the effect of forskolin and IBMX on cAMP level was stronger compare to
MRP4 inhibition.
Similarly when we transfected Mrp4-/- and Mrp4+/+ MEFs with cGMP sensor we
found that in the absence of MRP4 the Mrp4-/- MEFs show a higher basal level of
intracellular cGMP (Figure 4-13) compare to the MEFs that endogenously express
MRP4. After treatment with zaprinast, a specific PDE5 inhibitor, to the cGMP sensor
transfected fibroblasts the intracellular cGMP level increased more in Mrp4-/- MEFs than
in Mrp4+/+ MEFs. But after addition of zaprinast, there was a transient increase in cGMP
level whereas a sustained increase in cAMP level was obtained after forskolin and IBMX
treatment. However these data suggested that Mrp4-/- MEFs contain elevated levels of
cyclic nucleotide in basal condition and show a higher rise in cAMP and cGMP levels
upon forskolin-IBMX and zaprinast treatment respectively.
However, we and other have already shown the effect of MRP4 on intracellular
cyclic nucleotide dynamics and cyclic nucleotides are involved in many hallmark steps of
cell migration. Therefore we rationalized that the MRP4-mediated alteration of
intracellular cyclic nucleotide levels are important for the regulation of fibroblast
migration.
Mrp4-/- Fibroblasts Exhibit Moderately Elevated Levels of Cyclic Nucleotide
Using competitive immunoassays specific for cAMP and cGMP we further
noticed higher levels of intracellular cAMP and cGMP in MRP4-deficient MEFs. In these
competitive immunoassays, a polyclonal antibody for cAMP or cGMP competitively
bound with cyclic nucleotides present in the standards or sample, or an alkaline
phosphatase molecule conjugated cyclic nucleotides (Figure 4-14). Subsequent
incubation with substrate produced yellow color and the intensity of the color was
inversely proportional to the concentration of cyclic nucleotides. Protein concentrations
were measured for each sample and cAMP concentrations were represented as pmole per
mg of total protein for each sample.
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Figure 4-12. MRP4 deficient MEFs have moderately higher level intracellular
cAMP
Mrp4-/- or Mrp4+/+ MEFs were transfected with FRET based cAMP sensor, CFP-EPACYFP. The pseudocolor images of CFP/FRET before and 5 minute after addition of
forskolin (10µM) and IBMX (100µM) were shown and bar graphs represented the
CFP/FRET ratio in basal condition and after the treatment in Mrp4-/- or Mrp4+/+ MEFs.
Images in each panel were captured from the same field of view. Color bar showed the
magnitude of the emission ratio. All data represented at least three independent
experiments (n=3). * indicated P <0.05.
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Figure 4-13. MRP4 deficient MEFs have moderately higher level intracellular
cGMP
Mrp4-/- or Mrp4+/+ MEFs were transfected with FRET based cGMP sensor, Cygnet 2.1.
The pseudocolor images of CFP/FRET before and 5 minute after addition of zaprinast
(200µM) were shown and the bar graphs represented the CFP/FRET ratio in basal
condition and after the treatment in Mrp4-/- or Mrp4+/+ MEFs. Images in each panel were
captured from the same field of view. Color bar showed the magnitude of the emission
ratio. All data represented at least three independent experiments (n=3).
* indicated P <0.05.
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Figure 4-14. Competitive immunoassay for cyclic nucleotides
Illustrations showed steps involved in competitive immunoassay for cAMP and cGMP.
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The competitive immunoassay mediated measurement of cAMP showed that in
basal condition, Mrp4-/- MEFs contain moderately higher levels of intracellular cAMP
compare to the Mrp4+/+ MEFs. Treatment of Mrp4+/+ MEFs with 10µm forskolin and
100µM IBMX for 10 minutes, increased the intracellular cAMP level to a much higher
extent compare to the Mrp4-/-MEFs (Figure 4-15). The data suggested that the
intracellular cAMP level can be moderately regulated by MRP4 whereas forskolin and
IBMX treatment can strongly elevate the intracellular cAMP levels.
Similarly the competitive immunoassay mediated measurement of cGMP showed
that in basal condition, Mrp4-/- MEFs contain moderately higher levels of intracellular
cGMP compare to the Mrp4+/+ MEFs (Figure 4-16). Therefore both our FRET based
and ELISA based measurement of cyclic nucleotides confirmed that MRP4 can regulate
the intracellular cAMP and cGMP levels and due to reduced efflux transportation, Mrp4-/MEFs contain moderately higher levels of cyclic nucleotide compare to the wild type
cells.
Given that previous studies showed the effects of cyclic nucleotides on cell
migration, we rationalized that MRP4-mediated regulation of fibroblast migration is also
cyclic nucleotide-dependent.
Attenuated MEFs Migration in the Presence of Excessive cAMP
We demonstrated that the inhibition of MRP4 leads to accumulation of more
cAMP inside the cells and results in an increased migration rate. As the importance of
cAMP and PKA in directional migration is well established (97,98,100), we rationalized
that the global cAMP inducing agent forskolin, and a non-specific phosphodiesterase
inhibitor IBMX should also regulate cell migration in a similar fashion. Forskolin
activates the enzyme adenylyl cyclase and stimulate cAMP synthesis whereas IBMX
nonspecifically inhibits cAMP degradation by different isoforms of PDEs.
The strong elevation of cAMP with forskolin and reduced degradation with
IBMX treatment led to a robust increase in intracellular cAMP level. Hence we tried to
find the effect of forskolin and IBMX treatment on MEFs migration. To perform the
conventional in-vitro scratch wound assay, uniform wound were made using pipet tip on
the confluent monolayers of wild type MEFs treated with DMSO or forskolin-IBMX.
Cell migrations were monitored for 6 hours. When we measured the total cell migration
for 6 hours as a percentage of initial wound length we found that forskolin-IBMX treated
MEFs migrated significantly slower compare to the DMSO treated MEFs (Figure 4-17)
indicating a negative effect of forskolin-IBMX treatment on fibroblast migration. We
used high content microscopy to further confirm the data. The precise wounds were made
in the confluent monolayer of wild type MEFs treated with DMSO or forskolin-IBMX
and images were taken at 1hour interval for 18 hours using the IncuCyteTM live cell
imaging system. The Relative Wound Density (RDW) at every time point was measured.
Data revealed slower RWD kinetics for forskolin-IBMX treated MEFs compare to the
DMSO treated MEFs (Figure 4-18).
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Figure 4-15. ELISA-based measurement of cAMP
Bar graph represented the intracellular cAMP levels in Mrp4-/- MEFs, Mrp4+/+ MEFs and
forskolin (10µM) and IBMX (100µM) treated Mrp4+/+ MEFs. All data represented at
least three independent experiments (n=3). * indicated P <0.05.
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Figure 4-16. ELISA-based measurement of cGMP
Bar graph represented the intracellular cGMP levels in Mrp4-/- MEFs and Mrp4+/+ MEFs.
All data represents at least three independent experiments (n=3). * indicated P <0.05.
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Figure 4-17. Forskolin and IBMX inhibit MEFs migration in conventional wound
healing assay
The conventional wound healing assay was done with the DMSO or forskolin (10µM)
and IBMX (100µM) treated Mrp4+/+ MEFs and images were taken at 0th and 6th hour.
The initial and final wound lengths were calculated and cell migrations as a percentage of
initial wound length were represented in the bar graph. All data represented at least three
independent experiments (n=3). * indicated P <0.05.
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Figure 4-18. High content microscopy shows slower RWD kinetics for forskolin
and IBMX treated MEFs
DMSO or forskolin (10µM) and IBMX (100µM) treated Mrp4+/+ MEFs were grown on
fibronectin-coated 96-well Essen BioScience ImageLock dishes and the wounds were
made precisely using 96-pin Wound-Maker provided with the IncuCyteTM. The kinetic of
the Relative Wound Density (RWD) was analyzed by IncuCyteTM softwere. All data
represented at least three independent experiments (n=3).
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Inhibition of MRP4 Elevates Polarized cAMP in Migrating Fibroblasts
In contrast to the moderate cAMP elevation in absence of MRP4, the robust
increase in cAMP levels by forskolin and IBMX treatment significantly inhibited the
fibroblast migration rate. To investigate the opposing effect of forskolin and IBMX
treatment and inhibition of MRP4, we monitored the cAMP dynamics in those cells using
the CFP-PKA regulatory subunit and YFP-PKA catalytic subunit as FRET based cAMP
sensor. Binding of cAMP to the PKA-regulatory subunit induces the release of catalytic
subunits and therefore diminishes the FRET signal, followed by an increase in the donorto-FRET ratio (129,130).
We transfected the NIH 3T3 cells with those bimolecular FRET based sensor.
After 10 min of treatment with DMSO, MK571 or forskolin and IBMX, we monitored
the cAMP dynamics in those migrating fibroblasts. The migrating fibroblasts were
polarized into leading and trailing edges. We found that inhibition of MRP4 increases the
cAMP levels near the leading edge of a migration fibroblast whereas the forskolin-IBMX
treatment causes a robust increase in the cAMP levels all over the cell (Figure 4-19).
These data indicated that by inhibiting MRP4 we can elevate the cAMP levels
mostly near the leading edge and can augment cell polarization. In contrast forskolin and
IBMX treatment diminished the cell polarization by increasing the cAMP level
throughout the cells. Cell polarization is very important for directional cell migration, and
accumulation of cAMP preferentially at the leading edge induces polarized PKA
activation which is the hall mark step for directional cell migration (100,101). Therefore
forskolin and IBMX which strongly elevate the intracellular cAMP level had an
inhibitory effect on MEF cell migration whereas inhibition of MRP4 which moderately
increases the cAMP level inside the cell, stimulated cell migration.
Biphasic Effect of cAMP on MEF Cell Migration
We observed that the effect of MRP4 inhibition on fibroblast migration is
opposite to the effect of forskolin and IBMX treatment. This paradoxical effect of cAMP
on cell migration compelled us to investigate how cyclic nucleotides can regulate cell
migration in a concentration dependent manner. To investigate the effect of cAMP on
fibroblast migration we treated the MEFs with different concentrations of cell permeable
cpt-cAMP (0, 10, 20, 50, 100 and 200µM). Then we performed the conventional in-vitro
scratch wound assay by making uniform wound using pipet tip on the confluent
monolayers of wild type MEFs treated with different concentrations of cpt-cAMP. Cell
migrations were monitored for 6 hours. When we measured the total cell migration for 6
hours as a percentage of initial wound length we found that cAMP has a biphasic effect
on cell migration. Up to 20 µM cAMP can stimulate cell migration in a dose dependent
fashion but after that it started decreasing the migration rate (Figure 4-20). These data
indicated that cAMP can regulate cell migration in a concentration dependent fashion.
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Figure 4-19. Inhibition of MRP4 elevates cAMP accumulation at the leading edge
NIH3T3 cells were transfected with CFP-PKA regulatory subunit and YFP-PKA catalytic
subunit as FRET based cAMP sensor. The pseudocolor images represented the
CFP/FRET signal of DMSO, forskolin and IBMX and MK571 treated fibroblasts. Images
in each panel were captured from the same field of view. Color bar showed the
magnitude of the emission ratio.
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Figure 4-20. cAMP has a biphasic effect on fibroblast cell migration
The conventional wound healing assay was done with Mrp4+/+ MEFs and different
concentrations (0, 10, 20, 50, 100 and 200µM) of cell permeable cpt-cAMP. Images were
taken with 100X magnification at the 0th and 6th hour. The initial and final wound
lengths were calculated, and the fold increases in cell migration rates were representedin
the line graph. The intracellular cAMP concentration were measured by competitive
immunoassay for Mrp4-/-, Mrp4+/+ and forskolin (10µM) and IBMX (100µM) treated
Mrp4+/+ MEFs. The Intracellular cAMP levels corresponding to those cells were
indicated by arrows. All data represented at least three independent experiments (n=3).
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Quantification of Intracellular cAMP Concentrations
Next we quantitated the intracellular cAMP concentrations in Mrp4-/-, Mrp4+/+
and forskolin (10µM) and IBMX (100µM) treated Mrp4+/+ MEFs using competitive
immunoassay specific for cAMP. We trypsinized the cells, counted the number of cells in
each sample and measured the radius of a single Mrp4-/-or Mrp4+/+ MEF cell using phase
contrast microscopy. We found that the average radius (r) of those cells is ≈ 10µm. We
calculated the volume (V) of each cells accordingly (V= 4/3 πr3) and quantitated the
intracellular concentration of cAMP in µM for each types of cells after estimating the
total protein concentrations for each sample (111).
We noticed that the intracellular concentration of cAMP for Mrp4+/+ MEFs is ≈ 7
µM and for Mrp4-/- MEFs ≈ 10 µM. But a prolonged treatment with 10 µM forskolin and
100 µM IBMX (>30min) strongly increased the cAMP concentration up to ≈ 42µM
(Figure 4-20). The absence of MRP4 increased the intracellular cAMP concentration to a
level where cAMP exerts its stimulating effect on cell migration. But an extended
treatment with forskolin and IBMX increased the concentration further up and as a
consequence cell migration got inhibited. Together these data indicated that a moderate
elevation of cyclic nucleotide levels stimulates cell migration but that a further increase
leads to inhibition.
Biphasic Effect of cGMP on MEF Cell Migration
After revealing that cAMP has a biphasic effect on cell migration we tried to
investigate the effect of cGMP on fibroblasts migration. Therefore we treated the MEFs
with different concentrations of cell permeable cpt-cGMP (0, 10, 20, 50, 100 and
200µM). Then performed the conventional in-vitro scratch wound assay by making
uniform wound using pipet tip on the confluent monolayers of wild type MEFs treated
with different concentrations of cpt- cGMP. Cell migrations were monitored for 6 hours.
When we measured the total cell migration for 6 hours as a percentage of initial wound
length we found that cGMP has a similar biphasic effect but the concentration range for
stimulation was broader and effect was milder than that for cAMP. It stimulated
fibroblast migration up to 100µM concentration and then exerted the inhibitory effect
(Figure 4-21).
These data indicated that effect of cAMP on cell migration is stronger compare to
cGMP. At physiological concentrations the effect of cGMP on fibroblast migration was
rather stimulatory. The inhibitory effect was found at much higher concentration which is
not physiologically relevant. Additionally our FRET studies suggested that MRP4 has
higher affinity for cAMP at least in fibroblast cells. Therefore we rationalized that cAMP
plays a more important role in MRP4-dependent regulation of fibroblast migration.
However balanced and highly controlled intracellular cyclic nucleotide levels are
implicated as important in fibroblast migration.
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Figure 4-21. cGMP has a biphasic effect on fibroblast cell migration
The conventional wound healing assay was done with Mrp4+/+ MEFs and different
concentrations (0, 10, 20, 50, 100 and 200µM) of cell permeable cpt-cGMP. Images were
taken with 100X magnification at the 0th and 6th hour. The initial and final wound
lengths were calculated, and the fold increases in cell migration rates were represented in
the line graph. All data represented at least three independent experiments (n=3).
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Identification of MRP4 Interactome
We have already demonstrated that MRP4 plays important role in the regulation
of fibroblast migration via alteration of cyclic nucleotide levels. In order to completely
understand the effect of MRP4 on migratory phenomenon, it is required to identify the
proteins that act as downstream effectors of MRP4 in regulating cell migration. Therefore
we wanted to isolate MRP4 interactome and identify the interacting partners that are
known to be involved in migration related signaling cascades. We stably overexpressed
HA-MRP4 in HEK293 cells using lentivirus vector and purified MRP4 from those cells
using anti–HA beads. Figure 4-22 showed the Coomassie-stained gel of immuneprecipitated full-length HA-MRP4 and its interacting partners.
Then the major bands in the HA-MRP4 immunoprecipitated lane were subjected
to mass spectrometric (MS) analysis. MS analysis confirmed that we indeed purified full
length MRP4. We also identified hundreds of MRP4 interacting proteins. The functions
of MRP4 interacting partners were obtained from http://www.uniprot.org. The complete
list of MRP4 interactome, classified based on their molecular function, was provided in
Tables 4-1 to 4-11.
We also calculated the Mowse score to select the protein with high Mowse score
and remove the randomized interactions of low Mowse score. In peptide mass
fingerprinting a Mowse score represents “similarity score” based on the matching N
peaks probability by random chance. A high Mowse score will be assigned to a protein
sequence if it shows a high frequency of matched peaks or when a peak is exclusive.
We found that a large number of MRP4 interacting proteins including actin are
cytoskeleton related protein. That indicated the possible role of MRP4 in regulating
cytoskeleton dynamics during cell migration. With the help of Ingenuity Pathway
Analysis we assigned MRP4 as seed and the MRP4 interacting proteins as high
confidence (HC) interactome. To investigate the importance of MRP4 interactome in
various migration related signaling events, we checked the interconnectivity between
MRP4 and its interacting partners in the context of cell migration.
We used the “shortest path” explorer which also includes the intermediate
proteins and molecules involved in those pathway based on literature and experimental
evidences (Figure 4-23).We assigned MRP4 as seed (orange) and the MRP4 interacting
proteins as high confidence (HC) interactome (pink) and indicated the intermediate
proteins involved in the pathways based on literature and experimental evidences (Blue).
Subsequently we identified that several migration related signaling cascades
including actin polymerization and focal adhesion complex formation, are regulated by
certain nodes in the interactome network and cAMP and cGMP were also found to be the
important nodal points in the entire network.
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Figure 4-22. Immunoprecipitation of full-length HA-MRP4 for mass-spectrometric
analysis
MRP4 was affinity purified using anti HA-beads from HA-MRP4 overexpressed HEK
293 cells. The Coomassie-stained gel showed the immunoprecipitated full-length HAMRP4 and its interacting partners.
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Table 4-1.
List of chaperones identified by mass-spectrometric analysis in the
MRP4 interactome
Protein

Mowse score

Midasin

65.37

Heat shock cognate 71 kDa protein isoform 1

29.13
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Table 4-2.
List of cytoskeleton related proteins identified by mass-spectrometric
analysis in the MRP4 interactome
Protein

Mowse score

Dynein heavy chain domain-containing protein 1 isoform 1

184.98

Beta actin variant

59.71

Actin, gamma-enteric smooth muscle isoform 1 precursor

59.35

Rab GTPase-activating protein 1

54.99

Microtubule-actin cross-linking factor 1 isoform a

50.30

Nesprin-2

49.53

Polytrophic

48.02

Myosin-XVI isoform 2

42.85

Cytoplasmic FMR1 interacting protein 2

42.85

Myosin-9

41.26

Dynein heavy chain 3, axonemal

38.81

Kinesin-1 heavy chain

37.45

Kinesin heavy chain isoform 5A

37.45

Keratin, type I cytoskeletal 12

34.66

Gamma-tubulin complex component 5 isoform a

31.78

Cytokeratin 8

31.19

Titin isoform novex-3

156.41

Myotubularin related protein 8, isoform CRA_a

145.03
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Table 4-3.
List of transcription regulators identified by mass-spectrometric
analysis in the MRP4 interactome
Protein

Mowse score

Poly (ADP-ribose) polymerase family, member 3 isoform a variant

27.81

WD repeat domain 19, isoform CRA_a

31.92

RNA-binding protein FUS isoform 2

165.49

Transcription elongation factor B polypeptide 1 isoform b

9.68

Chromosome 3 open reading frame 21

97.58

RNA-binding protein EWS isoform 3

63.10

Leucine-rich repeat-containing protein 47

50.15

Leucine-rich repeat-containing protein 31

49.30

DNA polymerase epsilon, catalytic polypeptide

48.82

Terminal uridylyl transferase 4 isoform b

45.81

Zinc finger, CCHC domain containing 11

45.81

Leucine-rich repeat and IQ domain-containing protein 1

44.53

Bromo-domain adjacent to zinc finger domain 1B

44.24

KIAA0553 protein [Homo sapiens]

42.40

TAF15 RNA polymerase II,

35.94

hnRNP G protein

34.28

NF45 protein

34.01

Tho2

32.99

TGFB-induced factor homeobox 1

32.19

KIAA0309

31.78
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Table 4-4.
List of receptor proteins identified by mass-spectrometric analysis in
the MRP4 interactome
Protein

Mowse score

Olfactory receptor 2T35

823.07

Rap guanine nucleotide exchange factor (GEF) 1

31.78

ALS2

31.43

G protein-coupled receptor 155

20.86

FLJ00279 protein

39.19

TBC1 domain family, member 2B, isoform CRA_c

31.78

FERM, RhoGEF and pleckstrin domain-containing protein 2

15.68

SH2 domain containing 3C

94.63

Arf-GAP with SH3 domain, ANK repeat and PH domaincontaining protein 1

77.41

Adenylate cyclase type 5 isoform 1

47.13

Bile acid receptor isoform 3

48.85

Mannose receptor

15.47

Thyroid hormone receptor-associated protein complex component
TRAP220

13.78

CAS

10.36
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Table 4-5.
List of phosphorylation related proteins identified by massspectrometric analysis in the MRP4 interactome
Protein

Mowse score

Guanine nucleotide exchange factor Lbc

37.51

KIAA0213

37.45

Alpha-1 antitrypsin

34.04

cAMP-specific phosphodiesterase 8A

21.32

Serine/threonine-protein kinase Nek6 isoform 4

13.47

PAS-kinase

12.98

Janus kinase and microtubule-interacting protein 1

15.52

PI-3-kinase ATX

27.27

Mitogen- and stress-activated protein kinase-2

31.78

Titin, isoform CRA_a

201.51

Titin, isoform CRA_e

198.33

Dual specificity protein kinase TTK isoform 1

140.17

Muscle, skeletal, receptor tyrosine kinase

140.17

Small intestine SPAK-like kinase

73.13

Obscurin isoform a

54.51

Apoptosis signal-regulating kinase 2

42.85

Serine/threonine protein kinase

39.17

Serine/threonine-protein kinase D2 isoform A

10.35
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Table 4-6.
List of metabolism related proteins identified by mass-spectrometric
analysis in the MRP4 interactome
Protein

Mowse score

Group III secreted phospholipase A2

31.03

PSMD1 protein

29.95

CLEC16A protein

29.15

Monooxygenase, DBH-like 1, isoform CRA_a

141.39

Monooxygenase, DBH-like 1

141.39

Tyrosine hydroxylase isoform D1b,2,8,9

42.85

KIAA0455 protein

36.42

Polypeptide N-acetylgalactosaminyl transferase 3

33.39

Aspartyl/asparaginyl beta-hydroxylase isoform a

31.78

Cytochrome P450, family 2, subfamily C, polypeptide 18 variant

26.78
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Table 4-7.
List of ECM and adhesion related proteins identified by massspectrometric analysis in the MRP4 interactome
Protein

Mowse score

SCO-spondin precursor

27.37

Desmoplakin I

27.43

Trypsin-3 isoform 1 preproprotein

140.17

Plasminogen

64.03

Galectin-3-binding protein

42.95

ATP-dependent zinc metalloprotease YME1L1 isoform 3

42.85

LEKTI precursor

37.51

Collagen alpha-6(VI) chain precursor

34.88

Reelin isoform b

9.43
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Table 4-8.
List of ubiquitination related proteins identified by massspectrometric analysis in the MRP4 interactome
Protein

Mowse score

SSA1

86.2

F-box only protein 38 isoform b

73.13

Suppressor of cytokine signaling 7

69.75

Probable ubiquitin carboxyl-terminal hydrolase FAF-Y

47.37

Ubiquitin-conjugating BIR-domain enzyme APOLLON

33.91

Cullin 7

27.87

Autophagy-related protein 13 isoform 2

10.50

Cul-3

133.00

Midline-1 isoform 3

38.21
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Table 4-9.
List of apoptosis related proteins identified by mass-spectrometric
analysis in the MRP4 interactome
Protein

Mowse score

Periaxin, isoform CRA_b

142.88

unc-13 homolog B (C. elegans), isoform CRA_b

142.88

Caspase 3, apoptosis-related cysteine peptidase, isoform CRA_b

74.81

hCG1743181

34.88

Huntingtin

33.80

70

Table 4-10. List of ion channels and transporter proteins identified by massspectrometric analysis in the MRP4 interactome
Protein

Mowse score

Potassium channel

31.78

Multidrug resistance-associated protein

26.67

BRCA2

13.10

ATP-binding cassette, sub-family A (ABC1), member 13, isoform
CRA_a

13.09

Potassium channel subfamily K member 3

12.59

Sodium channel protein type 9 subunit alpha

12.18
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Table 4-11. List of various other proteins identified by mass-spectrometric
analysis in the MRP4 interactome
Protein

Mowse score

Function

Histone-arginine methyl
transferase CARM1

42.85

Methylation

p400 SWI2/SNF2-related
protein

58.7

Histone acetylation

ASH1

91.4

Histone-lysine N-methyl
transferase activity

PDZ domain-containing protein
8

19.15

Regulation of cell
morphogenesis

NuMA protein

36.56

Structural molecule activity
at apical part of cell

APC

68.28

Cell migration, adhesion.
Wnt pathway

Protein unc-13 homolog C

146.29

Exocytosis, metal ion and
diacylglycerol binding

KIAA1032 protein

142.88

Metal ion and diacylglycerol
binding

256 kD golgin

45.10

Golgi to plasma membrane
protein transport

KIAA0109

42.85

Protein transport, coated pit

Growth arrest-specific 8,
isoform CRA_c [

142.88

Antiproliferative, sperm
motility

Sister chromatid cohesion
protein PDS5 homolog B

33.41

Mitotic sister chromatid
cohesion
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Figure 4-23. Ingenuity Pathway Analysis (IPA) for MRP4 interactome
Ingenuity Pathway Analysis showed the interconnectivity between MRP4 interactome in
the context of cell migration. We assigned MRP4 as seed (orange) and the MRP4
interacting proteins as high confidence (HC) interactome (pink) and indicated the
intermediate proteins and molecules involved in the pathways based on literature and
experimental evidences (Blue).
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Actin and MRP4 Interaction
Interestingly using Ingenuity Pathway Analysis (IPA) we demonstrated that
significant numbers MRP4 interacting partners are involved in various signaling cascades
associated with the process of cell migration. This network and system biology based
approach provided a comprehensive perspective of MRP4 interactome in migration
related signaling events. Additionally we found that via alteration of cyclic nucleotide
levels, MRP4 can regulate some of its interacting partners that play important roles in
various signaling processes associated with cell migration. Given that no previous report
of a direct interaction between MRP4 and actin was found, we identified a novel
interaction between actin and MRP4 by mass-spectrometric analysis of the MRP4
interactome.
Notably we identified actin as an integral part of MRP4 containing
macromolecular complexes. It has been known for long that actin cytoskeleton plays
important role during the course of cell migration and dynamic rearrangement of actin at
the leading edge promotes the localized protrusion formation and efficient cell migration
(77,131). During cell migration, actin cytoskeletons get highly polymerized to form
cortical actin at the cortex region, a narrow zone just beneath the plasma membrane at the
leading edge. Before studying the effect of MRP4 on actin dynamics we verified the
endogenous association of actin with MRP4 in fibroblasts. Therefore we
immunoprecipitated MRP4 from Mrp4+/+ and Mrp4-/- MEFs using anti-MRP4 rabbit
polyclonal antibody. Our immunoblot data showed no MRP4 was immunoprecipitated in
Mrp4-/- MEFs but a significant amount of MRP4 was immunoprecipitated by anti-MRP4
antibody in Mrp4+/+ MEFs. We also found that actin is co-immunoprecipitated with
MRP4 (Figure 4-24). This data confirmed that actin interacts with MRP4 in fibroblast
cells.
To further confirm the MRP4-actin interaction we monitored their colocalizations in fibroblasts cells. We performed immunofluorescence staining for actin
and MRP4 using phalloidin Alexa Fluor 488 and anti-MRP4 rabbit polyclonal antibodyanti Rabbit Alexa Fluor 568 respectively in NIH3T3 cells. We observed that MRP4
expressed and co-localized with actin predominantly at the plasma membrane of NIH3T3
cells (Figure 4-25).
Next we performed immunofluorescence staining for actin and MRP4 using
phalloidin Alexa Fluor 488 and anti-MRP4 rabbit polyclonal antibody -anti Rabbit Alexa
Fluor 568 respectively in the confluent monolayers of Mrp4+/+ and Mrp4-/- MEFs. We
found that a significant population of actin is co-localized with MRP4 in Mrp4+/+ MEFs
compare to Mrp4-/- MEFs which do not express any MRP4 (Figure 4-26). The
quantification of actin and MRP4 co-localization was done using Imaris 7.7 Software.
Altogether our immunofluorescent and co-immunoprecipitations data supported the mass
spectroscopy based detection of MRP4 and actin interaction and led us to hypothesize the
possible role of actin as a key downstream effector protein for MRP4-mediated regulation
of fibroblast migration.
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Figure 4-24. Co-immunoprecipitation of actin with MRP4 from Mrp4+/+ MEFs
Endogenous MRP4 was immunoprecipitated from Mrp4+/+ and Mrp4-/- MEFs and
immunoblot data showed that actin is co-immunoprecipitated with MRP4.
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Figure 4-25. MRP4 co-localizes with actin predominantly at the plasma membrane
in NIH3T3 cells
Co-localization of MRP4 and actin in NIH3T3 cells was shown using anti-MRP4
antibody (red) and Phalloidin antibody (green) by confocal fluorescence microscopy
using 40 X objective, normal rabbit IgG was used as control.
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Figure 4-26. MRP4 co-localizes with actin in wild type MEF cells
Co-localization of MRP4 and actin in Mrp4+/+ and Mrp4-/- MEFs was shown using antiMRP4 antibody (red) and Phalloidin antibody (green) by confocal fluorescence
microscopy using 20 X objective and bar graph represented the percentage colocalization of MRP4 and F-actin compare to total F-actin. All data represented at least
three independent experiments (n=3). * indicated P <0.05.
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Actin Restricts MRP4 on the Cell Membrane
After revealing the fact that MRP4 can form a macromolecular complex with
actin at the plasma membrane, we tried to see the effect of actin cytoskeleton on MRP4
mobility at the cell membrane. As actin cytoskeleton has already been known to play an
important role in restricting several membrane proteins at specific domains of plasma
membrane (121,132) we hypothesized that actin can also restrict the surface mobility of
MRP4 molecules in fibroblasts.
To investigate the effects of actin cytoskeleton disruption on MRP4 mobility, we
used Latrunculin B which disrupts actin cytoskeleton by inducing de-polymerization of
actin filament. The dynamics of individual protein molecules in the plasma membrane of
a live cell can be successfully monitored by SPT (133), therefore we used the SPT
method to investigate the effects of actin cytoskeleton disruption on HA-MRP4 dynamics
in live NIH3T3 cells.
HA-MRP4 was labeled with biotin anti-HA antibody and then streptavidinconjugated Qdot-655 was added to tag the MRP4 protein on the plasma membrane. As
the HA tag on MRP4 protein was located between Gly 751 and 752 residues at the 4th
extracellular loop, antibodies can efficiently bind to the tag from outside without
penetrating the cell. Figure 4-27 showed that HA-MRP4 overexpressed cells were
successfully tagged with the Qdot-655 in presence but not in absence of biotin anti-HA
antibody. These data confirmed the specific labeling of HA-MRP4 with Qdot-655 in the
NIH3T3 cells.
After labeling we monitored that mobility of the individual Qdot-655 as a
representative of single MRP4 molecule using the particle-tracking module of SlideBook
4.2 software. The software also generated trajectories for single Qdot-655 and calculated
the mean square displacement and diffusion coefficient as index of lateral diffusion. To
monitor changes in the lateral diffusion of MRP4 in fibroblasts with cytoskeletal
disruption, cells were pretreated with Lat B (1 μM, 30 min) or DMSO (as control), and
were also added to the buffer during the course of the experiment.
We found that in control condition the mean diffusion coefficient of MRP4 is
0.016μm2/s. That denoted a confined diffusion of MRP4, which is comparable with the
diffusion coefficient of other membrane proteins (121). Treatment with Lat B (1 μM),
increased the diffusion coefficient of MRP4 almost by 2 fold (mean diffusion coefficient
0.03μm2/s) with longer trajectory paths (Figure 4-28A) and faster overall mobility
kinetics (Figure 4-28B and Figure 4-29).
Together our SPT data suggested that actin plays pivotal role in restricting MRP4
at specific micro-domains of plasma membrane and therefore can influence the MRP4mediated compartmentalized signaling.
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Figure 4-27. Qdot-655 labeled NIH 3T3 cells overexpressing HA-MRP4
Representative bright field and quantum dot labeled images of HA-MRP4 overexpressed
NIH3T3 cells treated with or without biotin α-HA antibody.

79

Figure 4-28. Disruption of actin cytoskeleton increases overall mobility kinetics of
MRP4
(A) SPT of HA-MRP4 in NIH3T3 cells represented by pseudocolor images showing
trajectories for individual HA -MRP4 molecule with DMSO or Lat B treatment. (B)
Representative mean squared displacement curve showed the overall mobility kinetics of
HA-MRP4 in DMSO or Lat B treated cells (n = 5-6 cells, 150–250 trajectories).
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Figure 4-29. Disruption of actin cytoskeleton increases MRP4 mobility on cell
membrane
Histograms represented the diffusion coefficients of a population of HA-MRP4 in the
plasma membrane of DMSO or Lat B treated NIH3T3 cells.
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Effect of Actin Cytoskeleton Disruption on MRP4 Function
Our SPT data suggested that disruption of actin cytoskeleton by Lat B enhances
the lateral diffusion of MRP4 molecules on the cell surface. Next we tried to investigate
the effect of Lat B treatment on MRP4 function using HA-MRP4 overexpressed HEK293
cells. We used 8-FcA as a fluorescent substrate for MRP4 (115) and measured the efflux
of 8-FcA by MRP4, two hours after treatment with DMSO, MK571 and Lat B. We found
that MK571 significantly reduced the MRP4 mediated efflux of 8-FcA but Lat B did not
show any effect on 8-FcA efflux rate (Figure 4-30). These data indicated that disruption
of actin cytoskeleton does not alter the function of MRP4. However we were not ruling
out the possibility of an altered MRP4-mediated compartmentalized signaling upon
disruption of actin cytoskeleton.
MRP4 Deficient Fibroblasts Exhibit Altered β-Actin Dynamics
Though our SPT data confirmed that actin cytoskeleton is responsible for
confining MRP4 localization but we did not find any direct impact of actin cytoskeleton
disruption on MRP4 function. Hence we tried to see if MRP4 itself can exert an effect on
cytoskeleton rearrangement during the course of cell migration.
To study the effect of MRP4 on actin dynamics, we fixed the wounded
monolayers of Mrp4+/+ and Mrp4-/- MEFs and stained them with Alexa Fluor 488
conjugated phalloidin antibody. During cell migration, actin cytoskeleton gets highly
polymerized at the cortex region, a narrow zone just beneath the plasma membrane at the
leading edge, and this actin-network is called cortical actin. We observed that there is a
thick cortical actin band at the wound edge of wild type and Mrp4-/- MEFs. Notably the
F- actin intensity at the wound edge was significantly higher in Mrp4-/- MEFs compare to
wild type MEFs (Figure 4-31).
Similarly in an individual migrating Mrp4-/- MEF the F-actin level was also much
higher compare to Mrp4+/+ MEF (Figure 4-32). Additionally in wild type cells distinct
MRP4 expressions were observed in the lamellipodia. These observations suggested that
at the leading edge MRP4 exerts a negative impact on cortical actin organization and
therefore the MRP4 deficient fibroblasts exhibit more intense cortical actin and faster
migration rate.
Increased cAMP Accumulation at the Leading Edge of Migrating Mrp4-/- MEFs
The polarized activation of cAMP dependent kinase PKA is an essential early step
for directional cell migration and it is also involved in actin polymerization and in the
regulation of cytoskeleton dynamics (99,100,102,104).
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Figure 4-30. Fluorescence based assay for MRP4 function
MRP4 function was measured using 8-FcA as MRP4 substrate. Bar graph represented the
amount of effluxed 8-FcA in HA-MRP4 overexpressed HEK293 cells treated with
DMSO, MK571 or Lat B. All data represented at least three independent experiments
(n=3). * indicated P <0.05.
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Figure 4-31. MRP4 deficient fibroblasts exhibit enhanced cortical actin network at
the wound edge
Cortical actin dynamics at the wound edges were shown in Mrp4+/+ and Mrp4-/- MEFs
using Phalloidin antibody (green) by confocal fluorescence microscopy using 20X
objective and bar graph represented the total actin intensity at the wound edge in Mrp4+/+
and Mrp4-/- MEFs. All data represented at least three independent experiments (n = 3).
* indicated P <0.05.
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Figure 4-32. MRP4 deficient fibroblasts exhibit an altered β-actin dynamics
Actin dynamics in migrating Mrp4+/+ and Mrp4-/- MEFs were shown using Phalloidin
antibody (green) and anti-MRP4 antibody (red) by confocal fluorescence microscopy
using 20 X objective.
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We have already demonstrated that in migrating fibroblast, inhibition of MRP4
enhances the polarized cAMP level at or near the leading edge. Here we used CFP and
YFP tagged PKA regulatory and catalytic subunits as FRET based cAMP sensor to
visualize the spatiotemporal dynamics of cAMP at the wound edge of the Mrp4+/+ and
Mrp4-/- MEFs.
In both cell types we observed polarized accumulation of cAMP at the leading
edge (Figure 4-33A). We also found that the total intracellular cAMP levels is higher in
Mrp4-/- MEFs compare to the Mrp4+/+ MEFs (Figure 4-33B). Additionally the difference
in cAMP levels between leading edge and cell body is significantly higher in Mrp4-/MEFs compare to the Mrp4+/+ MEFs (Figure 4-33C).
These data indicated that in absence of MRP4 there is an enhanced accumulation
of cAMP at or near the leading edge of a migrating fibroblast and these altered cAMP
dynamics plays an important role in regulating cell migration.
MRP4 Deficient Fibroblasts Exhibit Higher PKA Activity
As we found a higher level of cAMP in Mrp4-/- MEFs compare to the Mrp4+/+
MEFs, we rationalized that the overall PKA activity should also be higher in Mrp4-/MEFs. We measured the PKA activity by measuring phosphorylation profile of
immobilized PKA substrate on the microtiter plate in presence of ATP. Antibody specific
for phospho-PKA substrate recognized the immobilized phosphorylated substrate and got
detected by peroxidase conjugated anti rabbit IgG. Using this competitive immunoassay
based method we revealed a significantly higher total PKA activity in cells lacking
MRP4 (Figure 4-34).
This data was supported by an altered phosphorylation status of PKA substrate
VASP in the absence of MRP4. VASP contains three phosphorylation sites Ser-157, Ser239, and Thr-278 for cyclic nucleotide dependent serine and threonine kinases- PKA and
PKG (134,135). VASP can be phosphorylated by PKA at Ser 157 and it causes a shift in
the molecular mass of the protein in SDS-PAGE from 46 to 50 kDa. This indicated that,
that phosphorylation induces a change in the secondary structure of VASP (136).
Phosphorylation of VASP elevates its activity by relieving some inhibitory interactions.
However the phosphorylation of VASP may reduce the velocity of protrusion formation
but helps in the formation of persistent lamellipodia. Therefore the phosphorylation of
VASP plays important role in fibroblast migration (39,49).
To demonstrate the expression of VASP in fibroblast cells, we fixed the wounded
monolayers of Mrp4+/+ and Mrp4-/- MEFs and stained them with anti-VASP rabbit
monoclonal antibody and Alexa Fluor 488 conjugated anti rabbit antibody. We observed
that VASP is expressed predominantly at the tip of lamellipodia for both of the cell types.
Expression levels of VASP at the wound edges were found to be similar for Mrp4+/+ and
Mrp4-/- MEFs (Figure 4-35).
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Figure 4-33. MRP4 deficient fibroblasts exhibit increased total and polarized
cAMP levels
(A) The pseudocolor images of CFP/FRET with 60X magnification for Mrp4+/+ and
Mrp4-/- MEFs expressing cAMP sensor were shown. (B) The bar graphs represented the
CFP/FRET ratio indicating total intracellular cAMP levels in Mrp4+/+ and Mrp4-/- MEFs.
(C) The bar graphs represented the difference in CFP/FRET signal between leading edge
and cell body of Mrp4+/+ and Mrp4-/- MEFs. Images in each panel were captured from the
same field of view. Color bar showed the magnitude of the emission ratio. All data
representd at least three independent experiments (n=3). * indicated P <0.05.
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Figure 4-34. MRP4-deficient fibroblasts exhibit higher PKA activity
Bar graph represented total intracellular PKA activity in Mrp4+/+ and Mrp4-/- MEFs
measured by competitive immunoassay. All data represented at least three independent
experiments (n=3). * indicated P <0.05.
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Figure 4-35. Expression of VASP in MEFs
VASP expressions in Mrp4+/+ and Mrp4-/- MEFs were shown using anti- VASP antibody
(green) by confocal fluorescence microscopy using 20 X objective.
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When we investigated the level of phosphorylated VASP in MEFs, we found that
Mrp4 MEFs exhibit higher level of phosphorylation of VASP at Ser157 than the wild
type cells suggesting a higher PKA activity in the absence of MRP4 (Figure 4-36).
-/-

Mrp4-/- MEFs Exhibit Higher Levels of Polarized PKA Activity
Via the activation of their effector kinase (e.g., PKA and PKG) cyclic nucleotides
primarily execute their function in cells. FRET can be used as a powerful tool for
visualizing the PKA activity using the specific phosphorylation substrate peptide for
PKA flanked by CFP and YFP as sensor (137-140). The membrane targeted, forkheadassociated domain 1 (FHA1) and the PKA substrate sequence LRRATLVD containing
improved FRET based sensor for PKA (pmAKAR3) was used to monitor the polarized
PKA activation in the leading edge, which is an essential early hallmark step for
directional cell migration (100,141,142). The use of this FRET-based kinase sensors
provide useful tool for the identification of effector kinases that regulate various signaling
processes. They also contribute in detecting the correlation between cyclic nucleotide
dynamics and kinase activity in real time and space. Phosphorylation of pmAKAR3 by
PKA catalytic subunit increases the FRET signal between CFP and YFP by inducing a
conformational change. Insertion of a lipid modification domain to the sensor causes
targeting of the sensor specifically to the plasma membrane (143).
To check the specificity of pmAKAR3 for PKA activity we treated HEK293 cells
transfected with pmAKAR3 or the point mutant pmAKAR3-TA, which contains a
threonine-to-alanine mutation at substrate region for PKA and therefore irresponsive to
PKA phosphorylation, with 25 µM of forskolin. We found an increase in FRET signal in
cells expressing pmAKAR3 but that of the cells expressing pmAKAR3-TA remained
unaltered (Figure 4-37A). The basal FRET levels were also higher for cells expressing
pmAKAR3 compare to the cells expressing pmAKAR3-TA (Figure 4-37B). These data
indicated that pm AKAR3 sensor is very specific for PKA activity.
We made precise wound on the confluent monolayers of MEF cells transfected
with pmAKAR3 sensor. We selected cells expressing pmAKAR3 sensor particularly at
the wound edge. By monitoring the FRET signal we observed a polarized PKA activity at
the wound edge in both Mrp4-/- and Mrp4+/+ MEFs (Figure 4-38A). We also found that
the total intracellular PKA activity is higher in Mrp4-/- MEFs compare to the Mrp4+/+
MEFs (Figure 4-38B). Additionally the difference in PKA activity between leading edge
and trailing edge is also significantly higher in Mrp4-/- MEFs compare to the Mrp4+/+
MEFs (Figure 4-38C).
Together these observations indicated that in absence of MRP4 the elevated level
of cAMP induces the polarized PKA activation which in turn augments cell migration by
facilitating the cortical actin network formation at the leading edge.
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Figure 4-36. PKA-dependent phosphorylation of VASP in Mrp4-/- and Mrp4+/+
MEFs
Immunoblot data showed that PKA-dependent phosphorylation of VASP and bar graph
represented the ratio of phosphorylated VASP to the total VASP in Mrp4-/- and Mrp4+/+
MEFs. All data represented at least three independent experiments (n = 3).
* indicated P <0.05.
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Figure 4-37. FRET based measurement of PKA activity using pmAKAR3 sensor
(A) The pseudocolor images of N-FRET with 60X magnification for HEK293 cells
transfected with pmAKAR sensor and pmAKAR-TA sensor were shown. (B) The line
graphs represented the change in N-FRET levels after treatment with forskolin. Images in
each panel were captured from the same field of view. Color bar showed the magnitude
of the N-FRET. All data represents at least three independent experiments (n=3).
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Figure 4-38. MRP4 deficient fibroblasts exhibit increased total and polarized PKA
activity
(A) The pseudocolor images of N-FRET with 60X magnification for Mrp4+/+ and Mrp4-/MEFs expressing pmAKAR sensor were shown. (B) The bar graphs represented the NFRET signal indicating total intracellular PKA activity in Mrp4+/+ and Mrp4-/- MEFs. (C)
The bar graphs represented the difference in N-FRET signal between leading edge and
trailing edge of Mrp4+/+ and Mrp4-/- MEFs. Images in each panel were captured from the
same field of view. Color bar showed the magnitude of the N-FRET. All data represented
at least three independent experiments (n=3). * indicated P <0.05.
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Disruption of Actin Cytoskeleton Abrogates the Effect of MRP4 on Cell Migration
Using immunofluorescence staining in the wounded monolayers of MEFs we
revealed that much thicker cortical actin bands are formed at the wound edge of Mrp4-/MEFs compare to the Mrp4+/+ MEFs. The formation of cortical actin network at the
leading edge is an important hall mark step for directional cell migration. These data
indicated that MRP4 must exert its effect on cell migration by alteration of actin
cytoskeleton dynamics at the leading edge of a migrating fibroblast.
The altered actin dynamics in MRP4-deficient cells suggested that the effect of
MRP4 on cell migration is actin-dependent. Therefore we investigated the effect of actin
disruption on MRP4 dependent cell migration. Uniform wound were made using pipet tip
on the confluent monolayers of Mrp4-/- and Mrp4+/+ MEFs treated with DMSO or Lat B.
Then cell migrations were monitored only for 6 hours to minimize the effect of cell
proliferation.
In agreement with our previous study, the in vitro wound healing assay revealed
that Mrp4-/- MEFs move significantly faster compare to the Mrp4+/+ MEFs but the after
Lat B (1µl) treatment both of the cell types migrated at a similar rate which is much
slower than the basal migration rate of wild type fibroblasts (Figure 4-39A). In this assay
cell migration was monitored for 6 hours and was represented as a percentage of initial
wound length (Figure 4-39B).
Next we investigated the effect of Lat B treatment on MRP4 expression using
western blot. But our immunoblot data suggested that Lat B has no effect on MRP4
expression in MEFs (Figure 4-39C).
Additionally we used high-content microscopic technique to confirm the effect of
Lat B on fibroblast migration in vitro. After making precise wounds on the confluent
monolayer of MEFs, cells were treated with DMSO or Lat B (1µl) and images were taken
at 1hour intervals for 12 hours using the IncuCyteTM live cell imaging system and the
relative wound density was monitored for each time point.
We did not continue the assay for longer time as the effect of Lat B was not
sustained after 12 hours. Though the basal RWD kinetics is higher for Mrp4-/- MEFs, Lat
B treatment reduced the overall migration rate and both types of MEFs exhibited similar
RWD kinetics through the entire period of time (Figure 4-40).
Altogether these data indicated that disruption of actin cytoskeleton attenuates the
fibroblasts migration rate. Actin played an important role in regulating cAMP-dependent
regulation of fibroblast migration by MRP4. Disruption of actin polymerization
abrogated the effect of MRP4 on fibroblasts motility without affecting MRP4 expression
levels. Therefore we concluded that actin is the downstream target of MRP4 for
regulating fibroblast migration.
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Figure 4-39. Disruption of actin cytoskeleton abrogates the effect of MRP4 on cell
migration
(A) The conventional wound healing assay was performed on the in Mrp4+/+ and Mrp4-/MEFs treated with DMSO or Lat B, and images were taken with 10X magnification at
the 0th and 6th hour. (B) The initial and final wound lengths were calculated, and cell
migrations as a percentage of initial wound length were represented in the bar graph. (C)
The immune-blots data showed the expression of MRP4 in Mrp4+/+ and Mrp4-/- MEFs
treated with DMSO or Lat B. All data represented at least three independent experiments
(n=3). * indicated P <0.05.
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Figure 4-40. High content microscopy shows similar RWD kinetics for Lat B
treated Mrp4-/- and Mrp4+/+ MEFs
Mrp4+/+ and Mrp4-/- MEFs were grown on fibronectin-coated 96-well Essen BioScience
ImageLock dishes, and the wounds were made precisely using the 96-pin Wound-Maker
provided with the IncuCyteTM. The kinetics of the relative wound density (RWD) was
analyzed using IncuCyteTM software after treatment with DMSO or Lat B. All data
represented at least three independent experiments (n = 3).
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Inhibition of PKA Attenuates the Effect of MRP4 on Cell Migration by Alteration of
Cortical Actin Dynamics
As we observed that MRP4 exerts its effect on cell migration by modulating the
actin polymerization at the cell front, and previous studies showed the importance of
PKA in regulating actin based cell migration (99,100,103), we hypothesized that PKA act
as an intermediate effector protein for transmitting the effect of MRP4 on cortical actin
dynamics.
Therefore we investigated the effect of PKA inhibitor H-89 on MRP4-dependent
cell migration. Uniform wound were made using pipet tip on the confluent monolayers of
Mrp4-/- and Mrp4+/+ MEFs treated with DMSO or 50µM of H-89 (144). Then cell
migrations were monitored only for 6 hours to minimize the effect of cell proliferation.
In agreement with our previous study, the in vitro wound healing assay revealed
that Mrp4-/- MEFs move significantly faster compare to the Mrp4+/+ MEFs but the after
H-89 (50µM) treatment both of the cell types migrated at a similar rate with the basal
migration rate for wild type fibroblasts (Figure 4-41A). In this assay cell migration was
monitored for 6 hours and was represented as a percentage of initial wound length
(Figure 4-41B).
Our immunoblot data suggested that H-89 reduces the PKA mediated
phosphorylation of VASP and therefore a diminished phosphorylated VASP level was
detected in H-89 treated Mrp4-/- and Mrp4+/+ MEFs. However H-89 has no effect on
MRP4 and total VASP expressions in MEFs (Figure 4-41C).
Additionally we used high-content microscopic technique to confirm the effect of
PKA inhibition on fibroblast migration in vitro. After making precise wounds in the
confluent monolayer of MEFs, cells were treated with DMSO or H-89 (50µM) and
images were taken at 1hour intervals for 24 hour using the IncuCyteTM live cell imaging
system and the relative wound density was monitored for each time point. We found that
up to 8 hour, both of the cell types treated with H-89 migrate at a similar rate with the
basal migration rate for wild type fibroblasts. After that the H-89 treated cells started
migrating with a much slower rate compare to the control wild type cells. However the
RWD kinetics for H-89 treated Mrp4+/+ and Mrp4-/- MEFs were identical for the entire 24
hours period of time (Figure 4-42). These data indicated that inhibition of PKA can
abrogate the effect of MRP4 on fibroblast migration.
To understand the inhibitory effect of H-89 on cell migration, we treated wounded
monolayers of Mrp4+/+ and Mrp4-/- MEFs with 50 µM of H-89. After 4 hours cells were
fixed and stained with Alexa Fluor 488 conjugated phalloidin antibody. The
immunofluorescent data revealed that inhibition of PKA diminished the cortical actin
network formation at the wound edge and both Mrp4+/+ and Mrp4-/- MEFs showed
similar but reduced level of F-actin at the wound edge after treatment with PKA inhibitor
H-89 (Figure 4-43).
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Figure 4-41. Inhibition of PKA attenuates the effect of MRP4 on cell migration
A) The conventional wound healing assay was performed on the Mrp4+/+ and Mrp4-/MEFs treated with DMSO or PKA inhibitor H89, and images were taken with 10X
magnification at the 0th and 6th hour. (B) The initial and final wound lengths were
calculated, and cell migrations as a percentage of initial wound length were represented
in the bar graph. (C) The immune-blots data showed the expression of MRP4, phospho
VASP and total VASP in Mrp4+/+ and Mrp4-/- MEFs treated with DMSO or H89. All
data represented at least three independent experiments (n = 3). * indicated P <0.05.
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Figure 4-42. High content microscopy shows similar RWD kinetics for H-89
treated Mrp4-/- and Mrp4+/+ MEFs
Mrp4+/+ and Mrp4-/- MEFs were grown on fibronectin-coated 96-well Essen BioScience
ImageLock dishes, and the wounds were made precisely using the 96-pin Wound-Maker
provided with the IncuCyteTM. The kinetics of the relative wound density (RWD) was
analyzed using IncuCyteTM software after treatment with DMSO or H-89. All data
represented at least three independent experiments (n = 3).
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Figure 4-43. Inhibition of PKA induces multiple pseudopod formation in Mrp4-/and Mrp4+/+ MEFs
Actin dynamics at the wound edges of migrating Mrp4+/+ and Mrp4-/- MEFs were shown
using Phalloidin antibody (green) and anti-MRP4 antibody (red) by confocal microscopy
using 20 X objective.
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Most importantly inhibition of PKA induced the formation of multiple
pseudopods for both of the cell types denoting that PKA activity is essential for proper
cell polarization, localized protrusion formation at the direction of cell migration and
fine-tuned cell migration (Figure 4-43).
Together these results confirmed that PKA acts as a downstream effector of
MRP4 for executing its effects on actin polymerization and therefore on the overall cell
migration.
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CHAPTER 5.

DISCUSSION*

Cyclic Nucleotides Regulate Cell Migration
Our study demonstrated that inhibition of MRP4 stimulates fibroblast cell
migration by moderately increasing the intracellular cyclic nucleotides levels. In the year
1999, MRP4 was first identified as an endogenous efflux transporter of nucleoside-based
antiviral drugs in human T-lymphoid cell line (3,7).
Besides conferring drug resistance, MRP4 was also found to regulate diverse
physiological and pathological phenomena via alteration of the intracellular concentration
of its different endogenous substrates (27,145). However, among several endogenous
substrates MRP4 has been reported to have very high affinity for cAMP (Km = 45 µM)
and cGMP (Km = 10/180 µM), and these two cyclic nucleotides play important roles as
signaling molecules in many physiological and pathological events (18,19).
These elegant but simple secondary messengers regulate different complex
biological events, mostly via the activation of their target kinases (35-37,45,146,147).
Being a highly integrated multi-step process, cell migration plays a central role in
embryonic development, tissue repair, cancer, immune response and many other
physiological and pathological events (50,51).
Cyclic nucleotides play important roles in the signaling cascades associated with
the various stages of the cell migration, either directly or by activating their effector
kinases (146).
Polarized activation of cAMP-dependent protein kinases (PKA) at the leading
edge of a migrating cell is important for maintaining cell polarity and pseudopod
formation. The PKA-mediated directional migration requires activation of Rac GTPase
(100,101,103). Conversely, Rac-induced lamellipodia formation was inhibited by
elevated levels of cAMP (105). On the other hand, cGMP-dependent kinase (PKG) was
down regulated during VSMC cell migration (106).
But by phosphorylating VASP, PKG can relieve the negative effect of VASP on
the lamellipodia stability and maintain the repetitive behavior of cell migration (39).
These complex and equivocal effects of cyclic nucleotides on cell migration ensure the
importance of a tightly regulated and balanced intracellular cyclic nucleotide level for
fine-tuned cell migration.

*

Adapted with permission. This research was originally published in The Journal of Biological Chemistry.
Sinha, C., Ren, A., Arora, K., Moon, C. S., Yarlagadda, S., Zhang, W., Cheepala, S. B., Schuetz, J. D., and
Naren, A. P. Multi-drug resistance protein 4 (MRP4)-mediated regulation of fibroblast cell migration
reflects a dichotomous role of intracellular cyclic nucleotides, (2013) J Biol Chem, 288, 3786-3794. © the
American Society for Biochemistry and Molecular Biology.
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MRP4 Regulates Intracellular Cyclic Nucleotide Dynamics and Cell Migration
Together with our ex vivo skin explant outgrowth assay, the high-content
microscopy and conventional wound healing data indicated significantly increased cell
migration for MRP4-deficient MEF cells. These data suggested an important role for
MRP4 in regulating fibroblast migration. In similar experiments, inhibition of MRP4 by
MK571 significantly increased MEFs migration, whereas overexpression of MRP4
reduced the rate of wound healing indicating a negative effect of MRP4 on overall
fibroblast migration.
To understand the mechanism behind this process of regulation, we focused on
different endogenous substrates for MRP4 that are important for migratory events. As
MRP4 exhibits high affinities for cAMP and cGMP and these two second messengers
were already reported to be involved in different hallmark steps of cell migration (97), we
monitored the effect of MRP4 inhibition on intracellular cyclic nucleotide levels in
fibroblasts. Using FRET-based sensors specific for cAMP and cGMP, we observed that
inhibition of MRP4 by MK571 increases intracellular concentrations of both cAMP and
cGMP. But the effect was milder for cGMP compared to cAMP, indicating the higher
affinity of MRP4 for cAMP in fibroblasts.
Using the same sensors, we found higher basal levels of cAMP and cGMP for
Mrp4 MEFs. The intracellular cyclic nucleotide levels are regulated by
phosphodiesterase-mediated hydrolysis and by the process involving active transport out
of the cell (20,47). Zaprinast inhibits the breakdown of cGMP by PDE5 and thus
increases the intracellular cGMP level (148). In the absence of MRP4, the efflux of
cGMP from the cell was reduced, and therefore there was an increased accumulation of
intracellular cGMP. Hence the zaprinast-induced elevation of cGMP was also higher for
Mrp4-/- MEFs. Forskolin elevates the intracellular cAMP level by stimulating adenylate
cyclase (149,150). Therefore forskolin and the nonspecific phosphodiesterase inhibitor
IBMX caused a huge and prolonged increase in the intracellular cAMP level in MEFs
(151). Because of less cAMP efflux, the MRP4-deficient cells accumulated more cAMP
than Mrp4+/+ MEFs upon treatment with forskolin and IBMX.
-/-

We found a sustained and robust increase in cAMP level by forskolin and IBMX
treatment which results in inhibited fibroblast migration. Whereas an augmented
migration rate was observed by inhibiting MRP4 that induces a moderate increase in
cAMP level, mostly near the leading edge of a migrating fibroblast. Thus by elevation of
cAMP level at the cell front, MRP4 inhibition facilitates fibroblast polarization, a
hallmark step for directional cell migration.
In wound healing studies with cell-permeant cyclic nucleotides analogues, cptcAMP enhanced the fibroblasts migration up to 20 µM in a concentration-dependent
manner but after that, the effect was inhibitory. At basal condition the intracellular cAMP
concentration of Mrp4-/- MEFs was moderately higher than that of Mrp4+/+ MEFs (about
1.5 fold), and it fell within the stimulatory concentration range (1-20 µM). A prolonged
treatment (> 30 min) with forskolin and IBMX, however, increased the level further
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(about 6.5 fold), at which concentration the effect of cAMP is no longer stimulatory,
rather inhibitory to cell migration.
These data explained the opposing effects of MRP4 inhibition and forskolin,
IBMX treatment, on cell migration. A similar but milder biphasic effect was also
observed for cpt-cGMP which stimulated cell migration when used in concentrations up
to 100 µM. Hence, highly regulated intracellular cyclic nucleotides levels are implicated
as important in fine-tuned fibroblasts migration.
Role of Actin and PKA in Cell Migration
Cell migration is very important for embryonic development, wound healing,
immune response and a defective cell migration may lead to various pathologic
conditions like vascular diseases, tumor formation and cancer metastasis (37,51,52,70).
Establishment of cell polarity is indispensable for directional cell migration and restricted
activation cAMP dependent kinase at the leading edge is one of the key initiators for
promoting localized protrusions and thereby inducing directional cell migration
(100,103).
We also found that inhibition of MRP4 elevates the polarized cyclic cAMP at the
leading edge of a migrating fibroblast and this in turn augments the overall cell migration
rate. Studies have shown that at the leading edge, PKA activates small GTPases like Rac
and Cdc42 which are important for lamellipodia and filopodia formation respectively
during cell migration (50,72,76,99).
The phosphorylation activated Rac induces the WASP/ WAVE-mediated
activation of Apr 2/3 which binds at 70o to the sides or tips of pre-existing actin and
promotes the formation of dendritic actin network containing lamellipodia(50,51,73).
Additionally PKA dependent phosphorylation of VASP can also regulate the actin
polymerization and hence can control the protrusion formation in the direction of cell
migration (75).
Actin Is an Integral Part of MRP4 Interactome
In this study we purified MRP4 containing macromolecular complex from
HEK293 cells and using the network and system biology based approach we provided a
comprehensive perspective of MRP4 interactome in migration related signaling events.
Notably we identified actin as an integral part of MRP4 containing macromolecular
complexes and found that these two proteins associate with each other predominantly at
the plasma membrane of fibroblast cells. The interaction between actin and MRP4 helped
in restricting MRP4 in specific micro-domains of plasma membrane and disruption of
actin cytoskeleton caused almost two fold increases in lateral diffusion rate of MRP4 at
the cell surface.
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Though we did not find any direct effect of actin disruption on MRP4 function,
we are not ruling out the possible effect of actin on MRP4 dependent compartmentalized
signaling. While investigating the effect of MRP4 on actin dynamics, we observed that
the migrating Mrp4-/- MEFs exhibit a higher degree of actin polymerization and therefore
much intense cortical actin band at or near the leading edge compare to the wild type
cells. The simultaneous localization of MRP4 at the lamellipodia suggested a viable role
of MRP4 in regulating cytoskeleton dynamics and actin rearrangement at the cell
protrusions.
MRP4 Regulates PKA Activity in Fibroblast Cells
Question still remained how MRP4 regulates actin cytoskeleton. As we already
knew that inhibition of MRP4 leads to an polarized elevation of cAMP in migrating
fibroblasts, and cAMP/PKA can regulate the actin based cell migration (17,99), we
looked at the variability in cAMP dynamics between Mrp4+/+ and Mrp4-/- MEFs. We
used PKA based FRET sensor to monitor the spatiotemporal dynamics of cAMP at the
wound edge of migrating fibroblast. In agreement with previous studies (100,103), we
observed elevated cAMP levels at the leading edges of both types of migrating
fibroblasts. Not only the total intracellular cAMP but also the polarized cAMP levels
were found to be significantly higher in Mrp4-/- MEFs compare to the Mrp4+/+
fibroblasts. Using FRET based membrane bound PKA sensor pmAKAR3 we also found
that not only the total intracellular PKA activity but also the polarized PKA activity was
significantly higher in Mrp4-/- MEFs compare to the Mrp4+/+ fibroblasts.
These data indicated that in absence of MRP4, the increased accumulation of
cAMP at the leading edge activates more polarized PKA which in turn augments the
structured extension formation by inducing actin polymerization and therefore improves
the overall rate of cell migration.
PKA and Actin Are Downstream Effectors for MRP4-Dependent Regulation of
Fibroblast Migration
To further confirm our hypothesis, we studied the effect of actin in regulating
MRP4 dependent cell migration using wound healing assay. We observed that without
affecting the MRP4 protein expression, disruption of actin cytoskeleton completely
abrogates the effect of MRP4 on cell migration and both Mrp4+/+ and Mrp4-/- fibroblasts
start migrating with a similar rate after Lat B treatment. However Lat B treatment
significantly reduced the overall migration rate for both of the cell types.
To establish the possible role of PKA as an effector protein in this process of
regulation, we also studied the effect of PKA inhibition on fibroblast migration. In the
Mrp4-/- fibroblasts, the higher levels of cAMP led to an augmented PKA activity thereby
elevated VASP phosphorylation at Ser157 residue. But the PKA inhibitor H-89 treatment
suppressed the pVASP levels in both Mrp4+/+ and Mrp4-/- MEFs without affecting total
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VASP and MRP4 expressions. We found that after inhibition of PKA, both Mrp4+/+ and
Mrp4-/- MEFs migrate with similar rate as the untreated wild type MEFs for 8 h. Though
the migration rate further reduced after that but still both Mrp4+/+ and Mrp4-/- MEFs
maintained similar RWD kinetics. These data suggested that the effect of PKA inhibition
is much sustained compare to the Lat B treatment.
When we looked at the actin dynamics in those H-89 treated cells, we observed a
reduced cortical actin network formation at the wound edges. Most importantly inhibition
of PKA induced multiple pseudopod formation and impaired directionality in both
Mrp4+/+ and Mrp4-/- MEFs informing a pivotal role of PKA in promoting polarization
and localized protrusion formation during the course of directional migration.
Together our data suggested that inhibition of MRP4 elevates cAMP levels and
therefore activates more PKA at or near the leading edge of a migrating fibroblast. This
confined PKA activation enhanced the cell polarization and is the early hall mark step in
directional cell migration.
However in absence of MRP4-mediated cAMP efflux, the augmented PKA
activity stimulated actin polymerization probably via phosphorylation of VASP or
activation of small GTPase. Therefore it facilitated the formation of restricted and
localized structured extension specifically at the direction of cell migration (Figure 5-1).
Hence PKA acts as an intermediate effector protein to convey the effect of MRP4 on the
downstream target actin cytoskeleton for regulating fibroblast migration.
Although further study is required to identify the intermediate molecules that
carry the effect of PKA on actin dynamics and to unravel the entire molecular mechanism
behind the MRP4 dependent cell migration, our study demonstrated a novel cAMPdependent mechanism for MRP4-mediated regulation of fibroblast migration where PKA
and actin play critical roles as downstream targets.
Conclusions
In agreement to our findings, the knockdown of MRP4 was reported to enhance
human retinal vascular endothelial cell migration (126). In contrast, some other studies
with dendritic cells (145) and arterial smooth muscle cells (23) showed a stimulatory
effect of MRP4 on cell migration. This dichotomy of MRP4 as an effector for cell
migration may be related to the ambiguous role of cyclic nucleotides in migration
associated events and can be explained by the tissue-specific differential expression
levels of MRP4 and its interactome. Variation in MRP4-mediated regulation of
intracellular cyclic nucleotide dynamics and differential effects of cyclic nucleotides on
various cell types could be the major issue. Other endogenous substrates for MRP4 may
also be involved in the regulation of cell migration (3,34).
Altogether, our findings indicated that MRP4 can negatively regulate fibroblast
migration, at least in part, via a cyclic nucleotide-dependent manner.
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Figure 5-1. Schematic representation of mechanism of MRP4 dependent
fibroblast migration
The figure depicted that inhibition of MRP4 increases the intracellular cAMP levels
mostly near the leading edge of a migrating fibroblast, which in turn activates PKA. The
activated PKA increases the VASP phosphorylation and enhances the actin
polymerization at the cell front and thus facilitates cell migration.
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Our observation that inhibition of MRP4 increases fibroblast migration warrants
the use of MRP4 inhibitors like MK571 as new and potential wound healing agents. The
indirect effect on cancer metastasis should be taken into consideration during the use of
MRP4 inhibitor for reducing chemotherapy resistance in cancer patients. However
additional detailed studies are required to investigate the role of MRP4 in different types
of cancer metastasis. On the other hand, increase in intracellular cAMP level by
inhibition of MRP4 can be a good strategy to reduce fibroblasts to myofibroblasts
transformation (65,66) for preventing unwanted tissue fibrosis.
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